ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Therapeutic protocols
Every known protocol, with its status (in force / repealed), sublist, continuation by the family doctor and its medicines
| Code | Name | Status | Status since | ATC group | Sublist | GP | GP continuation conditions | Medicines (INN) | Other INNs mentioned in the text | Listed since | Last amended | Versions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A001E | ORLISTATUM | In force | A – Alimentary tract and metabolism | B | NO | ORLISTATUM | TESTOSTERONUM | November 2025 | November 2025 | 1 | ||
| A002C | PALONOSETRONUM | In force | A – Alimentary tract and metabolism | C1 -G10 | NO | PALONOSETRONUM | November 2025 | November 2025 | 1 | |||
| A004C | ONDASETRONUM, GRANISETRONUM | In force | A – Alimentary tract and metabolism | C1-G10 | * | * | GRANISETRONUM, ONDASETRONUM | DOMPERIDONUM, HALOPERIDOLUM, LEVOMEPROMAZINUM, LORAZEPAMUM, METOCLOPRAMIDUM | November 2025 | November 2025 | 1 | |
| A005E | PARICALCITOLUM | In force | A – Alimentary tract and metabolism | C1-G25 si C2 -P10 | NO | PARICALCITOLUM | ALFACALCIDOLUM, CALCITRIOLUM | November 2025 | November 2025 | 1 | ||
| A006E | CALCITRIOLUM | In force | A – Alimentary tract and metabolism | C2 -P10 | NO | CALCITRIOLUM | COLECALCIFEROLUM | November 2025 | November 2025 | 1 | ||
| A008E | IMIGLUCERASUM | In force | A – Alimentary tract and metabolism | C1-G29 | NO | IMIGLUCERASUM | VELAGLUCERASE ALFA | November 2025 | November 2025 | 1 | ||
| A010N | COMPLEX DE HIDROXID FER (III) SUCROZĂ | In force | A – Alimentary tract and metabolism | C1-G25 si C2 -P10 | NO | November 2025 | November 2025 | 1 | ||||
| A014E | AGALSIDASUM BETA | In force | A – Alimentary tract and metabolism | C2-P6.8 | NO | AGALSIDASUM BETA | AGALSIDASUM ALFA, CARBAMAZEPINUM, CLOPIDOGRELUM, GABAPENTINUM, METOCLOPRAMIDUM, MIGALASTATUM | November 2025 | April 2026 · 2 versions | 2 | ||
| A015E | INSULINUM LISPRO | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM LISPRO | PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A016E | INSULINUM ASPART | In force | A – Alimentary tract and metabolism | C2 -P5 | NO | INSULINUM ASPART | NICOTINUM | November 2025 | November 2025 | 1 | ||
| A017E | INSULINUM LISPRO | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM LISPRO | November 2025 | November 2025 | 1 | |||
| A018E | INSULINUM ASPART | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM ASPART | PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A019E | INSULINUM GLULIZINA | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM GLULIZINA | PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A020E | PIOGLITAZONUM | In force | A – Alimentary tract and metabolism | C2 -P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | PIOGLITAZONUM | METFORMINUM | November 2025 | November 2025 | 1 | |
| A021E | ACIDUM TIOCTICUM (ALFA-LIPOICUM) | In force | A – Alimentary tract and metabolism | B | YES | ACIDUM TIOCTICUM, ALFA-LIPOICUM | CISPLATINUM | November 2025 | July 2026 · 2 versions | 2 | ||
| A022E | SITAGLIPTINUM | In force | A – Alimentary tract and metabolism | C2 -P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | SITAGLIPTINUM | METFORMINUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | |
| A023E | INSULINUM DETEMIR | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM DETEMIR | AMINOACIZI, INSULINUM ASPART | November 2025 | November 2025 | 1 | ||
| A024E | INSULINUM GLARGINE | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM GLARGINE | PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A025E | COMBINAŢII (PIOGLITAZONUM + METFORMIN) | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | METFORMINUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A029E | INSULINUM LISPRO | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM LISPRO | PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A030Q | AGLUCOSIDASUM ALFA | In force | A – Alimentary tract and metabolism | C2-P6.9 | NO | AGLUCOSIDASUM, ALGLUCOSIDASUM ALFA | November 2025 | November 2025 | 1 | |||
| A03AB02 | GLICOPIRONIUM BROMIDUM | In force | A – Alimentary tract and metabolism | C3 | NO | GLICOPIRONIU BROMIDUM, GLICOPIRONIUM BROMIDUM | CLOZAPINUM, CODEINUM, DOMPERIDONUM, HALOPERIDOLUM, METOCLOPRAMIDUM, TOPIRAMATUM | April 2026 | April 2026 | 1 | ||
| A04AA55 | COMBINAȚII (NETUPITANTUM + PALONOSETRONUM) | In force | A – Alimentary tract and metabolism | C1-G10 | NO | NETUPITANTUM, PALONOSETRONUM | CISPLATINUM | November 2025 | November 2025 | 1 | ||
| A05AA04 | ACID OBETICHOLICUM | Repealed · January 2026 | January 2026 | A – Alimentary tract and metabolism | C1-G6 | NO | OBETICHOLICUM | November 2025 | November 2025 | 1 | ||
| A05AX04 | MARALIXIBATUM | In force | A – Alimentary tract and metabolism | C1-G22 | NO | MARALIXIBATUM | MIDAZOLAMUM, RIFAMPICINUM, ROSUVASTATINUM, SIMVASTATINUM | April 2026 | April 2026 | 1 | ||
| A05AX05 | ODEVIXIBATUM | In force | A – Alimentary tract and metabolism | C1-G22 | NO | ODEVIXIBATUM | RIFAMPICINUM | April 2026 | April 2026 | 1 | ||
| A07EA06 | BUDESONIDUM | In force | A – Alimentary tract and metabolism | C1-G25 | NO | BUDESONIDUM | April 2026 | April 2026 | 1 | |||
| A09AA02 | PANCREATINUM (concentraţia 35.000 U FE) | In force | A – Alimentary tract and metabolism | A | YES | PANCREATINUM | November 2025 | November 2025 | 1 | |||
| A10AD06 | COMBINAȚII INSULINUM DEGLUDEC + INSULINUM ASPART | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM ASPART, INSULINUM DEGLUDEC | INSULINUM DETEMIR, INSULINUM GLARGINE | November 2025 | November 2025 | 1 | ||
| A10AE06 | INSULINUM DEGLUDEC | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM DEGLUDEC | GLUCAGONUM, INSULINUM DETEMIR, INSULINUM GLARGINE, LANREOTIDUM, OCTREOTIDUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A10AE54 | COMBINATII (INSULINE GLARGINE+LIXISENATIDUM) | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM GLARGINE, LIXISENATIDUM | GLUCAGONUM, METFORMINUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A10AE56 | COMBINATII INSULINUM DEGLUDEC+LIRAGLUTIDUM | In force | A – Alimentary tract and metabolism | C2-P5 | NO | INSULINUM DEGLUDEC, LIRAGLUTIDUM | GLUCAGONUM, METFORMINUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | ||
| A10BD07 | COMBINAŢII (SITAGLIPTINUM + METFORMINUM) | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | METFORMINUM, SITAGLIPTINUM | November 2025 | November 2025 | 1 | ||
| A10BD08 | COMBINAȚII (VILDAGLIPTIN+METFORMIN) | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | METFORMINUM, VILDAGLIPTINUM | SAXAGLIPTINUM | November 2025 | November 2025 | 1 | |
| A10BD10 | COMBINAŢII (SAXAGLIPTINUM + METFORMINUM) - concentraţia 2,5 mg/1000 mg | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | METFORMINUM, SAXAGLIPTINUM | November 2025 | November 2025 | 1 | ||
| A10BD15 | COMBINAȚII (DAPAGLIFLOZINUM + METFORMINUM) | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | DAPAGLIFLOZINUM, METFORMINUM | November 2025 | November 2025 | 1 | ||
| A10BD20 | COMBINAȚII EMPAGLIFLOZINUM + METFORMINUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA,în dozele şi pe durata recomandată în scrisoarea medicală | EMPAGLIFLOZINUM, METFORMINUM | November 2025 | November 2025 | 1 | ||
| A10BD21 | COMBINAȚII (SAXAGLIPTIN+DAPAGLIFLOZINUM) | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | DAPAGLIFLOZINUM, SAXAGLIPTINUM | METFORMINUM | November 2025 | November 2025 | 1 | |
| A10BD24 | COMBINAȚII ERTUGLIFLOZINUM + SITAGLIPTINUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA,în dozele şi pe durata recomandată în scrisoarea medicală | ERTUGLIFLOZINUM, SITAGLIPTINUM | METFORMINUM | November 2025 | November 2025 | 1 | |
| A10BH02 | VILDAGLIPTINUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | VILDAGLIPTINUM | METFORMINUM | November 2025 | November 2025 | 1 | |
| A10BH03 | SAXAGLIPTINUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | SAXAGLIPTINUM | METFORMINUM | November 2025 | November 2025 | 1 | |
| A10BJ01 | EXENATIDUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, doar pentru pacienții cu schema stabilă, în dozele şi pe durata recomandată în scrisoarea medicală | EXENATIDUM | DAPAGLIFLOZINUM, METFORMINUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | |
| A10BJ02 | LIRAGLUTIDUM | In force | A – Alimentary tract and metabolism | C2- P5 | YES | DA, doar pentru pacienții cu schema stabilă, în dozele şi pe durata recomandată în scrisoarea medicală | LIRAGLUTIDUM | ATORVASTATINUM, DIGOXINUM, LISINOPRILUM, METFORMINUM, PARACETAMOLUM | November 2025 | November 2025 | 1 | |
| A10BJ05 | DULAGLUTIDUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, doar pentru pacienții cu schema stabilă, în dozele şi pe durata recomandată în scrisoarea medicală | DULAGLUTIDUM | METFORMINUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | |
| A10BJ06 | SEMAGLUTIDUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, doar pentru pacienții cu schema stabilă, în dozele şi pe durata recomandată în scrisoarea medicală | SEMAGLUTIDUM | METFORMINUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | |
| A10BK01 | DAPAGLIFLOZINUM | In force | A – Alimentary tract and metabolism | C1-G25 | YES* | INITIERE la pacienții cu boală cronică de rinichi cu risc moderat, DA, în dozele și pe durata recomandată în scrisoarea medicală, | DAPAGLIFLOZINUM | GLUCAGONUM | November 2025 | July 2026 · 2 versions | 2 | |
| A10BK01-03 | INSUFICIENTA CARDIACA CRONICA (DAPAGLIFLOZINUM,EMPAGLIFLOZINUM) | In force | A – Alimentary tract and metabolism | C1-G1 | YES | DA, pe durata prevăzută în scrisoarea medicală | DAPAGLIFLOZINUM, EMPAGLIFLOZINUM | November 2025 | November 2025 | 1 | ||
| A10BK03 | EMPAGLIFLOZINUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | EMPAGLIFLOZINUM | METFORMINUM | November 2025 | November 2025 | 1 | |
| A10BX09 | DAPAGLIFLOZINUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, în dozele şi pe durata recomandată în scrisoarea medicală | DAPAGLIFLOZINUM | METFORMINUM | November 2025 | November 2025 | 1 | |
| A10BX10 | LIXISENATIDUM | In force | A – Alimentary tract and metabolism | C2-P5 | YES | DA, doar pentru pacienții cu schema stabilă, în dozele şi pe durata recomandată în scrisoarea medicală | LIXISENATIDUM | GLUCAGONUM, METFORMINUM, PIOGLITAZONUM | November 2025 | November 2025 | 1 | |
| A11DA03 | BENFOTIAMINUM | In force | A – Alimentary tract and metabolism | D | YES | DA(si initiere) | BENFOTIAMINUM | November 2025 | July 2026 · 2 versions | 2 | ||
| A11DBN1 | COMBINATII | In force | A – Alimentary tract and metabolism | D | YES | DA(si initiere) | November 2025 | July 2026 · 2 versions | 2 | |||
| A16AA04 | MERCAPTAMINUM | In force | A – Alimentary tract and metabolism | C2-P6.27 | NO | MERCAPTAMINUM | AMINOACIZI, TESTOSTERONUM | November 2025 | November 2025 | 1 | ||
| A16AA07 | METRELEPTINUM | In force | A – Alimentary tract and metabolism | C1-G22 | NO | METRELEPTINUM | ESTRADIOLUM, FIBRINOGEN, TESTOSTERONUM | November 2025 | November 2025 | 1 | ||
| A16AB03 | AGALSIDASUM ALFA | In force | A – Alimentary tract and metabolism | C2-P6.27 | NO | AGALSIDASUM ALFA | AGALSIDASUM BETA, CARBAMAZEPINUM, CLOPIDOGRELUM, GABAPENTINUM, METOCLOPRAMIDUM, MIGALASTATUM | November 2025 | April 2026 · 2 versions | 2 | ||
| A16AB09 | IDURSULFASE | In force | A – Alimentary tract and metabolism | C2-P6.12 | NO | IDURSULFASUM | November 2025 | November 2025 | 1 | |||
| A16AB10 | VELAGLUCERASE ALFA | In force | A – Alimentary tract and metabolism | C1-G29 | NO | VELAGLUCERASE ALFA | IMIGLUCERASUM | November 2025 | November 2025 | 1 | ||
| A16AB12 | ELOSULFASE ALFA | In force | A – Alimentary tract and metabolism | C2-P6.26 | NO | ELOSULFASE ALFA | November 2025 | November 2025 | 1 | |||
| A16AB13 | ASFOTAZA ALFA | In force | A – Alimentary tract and metabolism | C1-G22 | NO | ASFOTAZA | ASFOTASE ALFA, OXIGENUM | April 2026 | April 2026 | 1 | ||
| A16AB14 | SEBELIPASE ALFA | In force | A – Alimentary tract and metabolism | C2-P 6.27 | NO | SEBELIPASE ALFA | April 2026 | April 2026 | 1 | |||
| A16AB15 | VELMANAZA ALFA | In force | A – Alimentary tract and metabolism | C2-P6.27 | NO | VELMANAZA ALFA | November 2025 | November 2025 | 1 | |||
| A16AB17 | CERLIPONASUM ALFA | In force | A – Alimentary tract and metabolism | C2-P6.27 | NO | CERLIPONASUM ALFA | November 2025 | November 2025 | 1 | |||
| A16AB20 | PEGUNIGALSIDASUM ALFA | In force | A – Alimentary tract and metabolism | C2-P 6.27 | NO | PEGUNIGALSIDASUM ALFA | AGALSIDASUM ALFA, AMINOACIZI, CARBAMAZEPINUM, CLOPIDOGRELUM, GABAPENTINUM, METOCLOPRAMIDUM | April 2026 | April 2026 | 1 | ||
| A16AB25 | OLIPUDASE ALFA | In force | A – Alimentary tract and metabolism | C2-P6.31 | NO | OLIPUDASE, OLIPUDASUM ALFA | November 2025 | November 2025 | 1 | |||
| A16AX03 | NATRII PHENYLBUTYRATE | In force | A – Alimentary tract and metabolism | C1-G22 | NO | NATRII PHENYLBUTYRATE | AMINOACIZI, ARGININUM, HALOPERIDOLUM | November 2025 | November 2025 | 1 | ||
| A16AX04 | NITISINONUM | In force | A – Alimentary tract and metabolism | C1-G22 | NO | NITISINONUM | April 2026 | April 2026 | 1 | |||
| A16AX06 | MIGLUSTAT | In force | A – Alimentary tract and metabolism | C1-G29/C1-G12 | NO | MIGLUSTATUM | BACLOFENUM, ELIGLUSTAT, IMIGLUCERASUM | November 2025 | April 2026 · 2 versions | 2 | ||
| A16AX07 | PLERIXAFOR | In force | A – Alimentary tract and metabolism | C2-P9.1 | NO | PLERIXAFORUM | OXIGENUM | November 2025 | November 2025 | 1 | ||
| A16AX07S | SAPROPTERINUM | In force | A – Alimentary tract and metabolism | C2-P6.18 | NO | SAPROPTERINUM | November 2025 | November 2025 | 1 | |||
| A16AX08 | TEDUGLUTIDUM | In force | A – Alimentary tract and metabolism | C1-G31a | NO | TEDUGLUTIDUM | GLUCAGONUM | November 2025 | July 2026 · 2 versions | 2 | ||
| A16AX09 | GLYCEROLI PHENYLBUTYRAS | In force | A – Alimentary tract and metabolism | C1-G22 | NO | GLYCEROLI PHENYLBUTYRAS, GLYCEROLUM | AMINOACIZI, ARGININUM, HALOPERIDOLUM | November 2025 | November 2025 | 1 | ||
| A16AX10 | ELIGLUSTAT | In force | A – Alimentary tract and metabolism | C1-G29 | NO | ELIGLUSTAT | AMIODARONUM, IMIGLUCERASUM, SOTALOLUM | November 2025 | November 2025 | 1 | ||
| A16AX14 | MIGALASTATUM | In force | A – Alimentary tract and metabolism | C2-P 6.8 | NO | MIGALASTATUM | AGALSIDASUM BETA, AMINOACIZI, CARBAMAZEPINUM, CLOPIDOGRELUM, GABAPENTINUM, METOCLOPRAMIDUM | November 2025 | April 2026 · 2 versions | 2 | ||
| A16AX16 | GIVOSIRAN | In force | A – Alimentary tract and metabolism | C1-G22 | NO | GIVOSIRANUM | OXIGENUM | November 2025 | November 2025 | 1 | ||
| A16AX18 | LUMASIRANUM | In force | A – Alimentary tract and metabolism | C1-G25 | NO | LUMASIRANUM | AMINOACIZI | November 2025 | November 2025 | 1 | ||
| AE01E | PROTOCOL TERAPEUTIC ÎN DIABETUL ZAHARAT | In force | A – Alimentary tract and metabolism | C2-P5 | DAPAGLIFLOZINUM, DULAGLUTIDUM, EMPAGLIFLOZINUM, EXENATIDUM, GLIBENCLAMIDUM … | DAPAGLIFLOZINUM, DULAGLUTIDUM, EMPAGLIFLOZINUM, EXENATIDUM, GLIBENCLAMIDUM, GLICLAZIDUM, GLIMEPIRIDUM, GLIPIZIDUM, GLIQUIDONUM, GLUCAGONUM, INSULINUM DEGLUDEC, INSULINUM DETEMIR, INSULINUM GLARGINE, LINAGLIPTINUM, LIRAGLUTIDUM, LIXISENATIDUM, METFORMINUM, PIOGLITAZONUM, REPAGLINIDUM, SAXAGLIPTINUM, SEMAGLUTIDUM, SITAGLIPTINUM, VILDAGLIPTINUM | November 2025 | November 2025 | 1 | |||
| B008D | PROTOCOL PENTRU PROFILAXIA ŞI TRATAMENTUL TROMBOEMBOLISMULUI VENOS ÎN AMBULATOR | In force | B – Blood and blood forming organs | B, dalteparin, enoxaparin(original și biosimilar), nadroparin, reviparin, tinzaparin, fondaparinux | YES | APIXABANUM, DALTEPARINUM, ENOXAPARINUM, HEPARINUM, NADROPARINUM … | APIXABANUM, DALTEPARINUM, ENOXAPARINUM, HEPARINUM, NADROPARINUM, RIVAROXABANUM, TINZAPARINUM | November 2025 | November 2025 | 1 | ||
| B009I | CLOPIDOGRELUM | In force | B – Blood and blood forming organs | B si C1-G3 | YES | CLOPIDOGRELUM | November 2025 | November 2025 | 1 | |||
| B009N | EPOETINUM BETA | In force | B – Blood and blood forming organs | C1-G25 si C2 -P10 | NO | EPOETINUM BETA | November 2025 | November 2025 | 1 | |||
| B010N | EPOETINUM ALFA | In force | B – Blood and blood forming organs | C1-G25 si C2 -P10 | NO | EPOETINUM ALFA | November 2025 | November 2025 | 1 | |||
| B011N | DARBEPOETINUM ALFA | In force | B – Blood and blood forming organs | C1-G25 si C2 -P10 | NO | DARBEPOETINUM ALFA | EPOETINUM | November 2025 | November 2025 | 1 | ||
| B013K | MEDICAŢIA ADJUVANTĂ TERAPIEI ANTIVIRALE ÎN HEPATITE CRONICE (FILGRASTIM) | In force | B – Blood and blood forming organs | C1-G4, G7 | * | * | FILGRASTIMUM | INTERFERONUM | November 2025 | November 2025 | 1 | |
| B014I | SULODEXIDUM(original și biosimilar) | In force | B – Blood and blood forming organs | B | YES | SULODEXIDUM | FIBRINOGEN, HEPARINUM, TROMBINA | November 2025 | November 2025 | 1 | ||
| B015D | EPTACOG ALFA ACTIVATUM | In force | B – Blood and blood forming organs | C2-P6.1 | NO | EPTACOG ALFA ACTIVATUM | November 2025 | November 2025 | 1 | |||
| B016I | DIOSMINUM | In force | B – Blood and blood forming organs | D | YES | DA (si initere) | DIOSMINUM | November 2025 | November 2025 | 1 | ||
| B01AC21-HTAP | TREPROSTINILUM | In force | B – Blood and blood forming organs | C2-P6.3 | NO | TREPROSTINILUM | AMBRISENTANUM, BOSENTANUM, MACITENTANUM, RIOCIGUAT, SELEXIPAGUM, SILDENAFILUM, TADALAFILUM | November 2025 | November 2025 | 1 | ||
| B01AC21-HTAPCT | TREPROSTINILUM | In force | B – Blood and blood forming organs | C2-P6.3 | NO | TREPROSTINILUM | AMBRISENTANUM, BOSENTANUM, MACITENTANUM, RIOCIGUAT, SELEXIPAGUM, SILDENAFILUM, TADALAFILUM | November 2025 | November 2025 | 1 | ||
| B01AC24 | TICAGRELOR | In force | B – Blood and blood forming organs | C1-G3 | YES | TICAGRELOR | ATAZANAVIRUM, KETOCONAZOLUM, RITONAVIRUM | November 2025 | January 2026 · 2 versions | 2 | ||
| B01AC27 | SELEXIPAGUM | In force | B – Blood and blood forming organs | C2-P6.3 | NO | SELEXIPAGUM | AMBRISENTANUM, BOSENTANUM, CLOPIDOGRELUM, DEFERASIROXUM, ILOPROSTUM, MACITENTANUM, RIOCIGUAT, SILDENAFILUM, TADALAFILUM, TERIFLUNOMIDUM, TREPROSTINILUM | November 2025 | November 2025 | 1 | ||
| B01AE-B01AF | ANTICOAGULANTE ORALE NON-ANTI VITAMINA K (NOAC) | In force | B – Blood and blood forming organs | B | YES | DA, in dozele şi pe durata recomandată în scrisoarea medicală, cu exceptia cazurilor de prevenire a evenimentelor tromboembolice venoase la pacienţii adulţi care sunt supuşi unei intervenţii chirurgicale de artroplastie a şoldului sau genunchiului | APIXABANUM, CICLOSPORINUM, DABIGATRANUM ETEXILATUM, EDOXABANUM, HEPARINUM … | APIXABANUM, CICLOSPORINUM, DABIGATRANUM ETEXILATUM, EDOXABANUM, HEPARINUM, KETOCONAZOLUM, RIVAROXABANUM, VERAPAMILUM | November 2025 | January 2026 · 2 versions | 2 | |
| B01AX07 | CAPLACIZUMABUM | In force | B – Blood and blood forming organs | C2-P6.27 | NO | CAPLACIZUMABUM | CICLOSPORINUM, CLOPIDOGRELUM, FACTOR VON WILLEBRAND, HEPARINUM, TICLOPIDINUM | November 2025 | November 2025 | 1 | ||
| B02AB02 | INHIBITOR ALFA 1 PROTEINAZA UMANA | In force | B – Blood and blood forming organs | C1-G31H | NO | OXIGENUM | OXIGENUM | November 2025 | November 2025 | 1 | ||
| B02BD02 | RURIOCTOCOG ALFA PEGOL | In force | B – Blood and blood forming organs | C2- P6.27 | NO | RURIOCTOCOG ALFA PEGOL | AMINOACIZI, OCTOCOG ALFA, TROMBINA, TUROCTOCOG ALFA PEGOL | November 2025 | November 2025 | 1 | ||
| B02BD02-TUROCTO | TUROCTOCOG ALFA PEGOL | In force | B – Blood and blood forming organs | C2-P6.27 | NO | November 2025 | November 2025 | 1 | ||||
| B02BD14 | SUSOCTOCOG ALFA | In force | B – Blood and blood forming organs | C2-P6.1 | NO | SUSOCTOCOG ALFA | November 2025 | November 2025 | 1 | |||
| B02BX04 | ROMIPLOSTINUM | In force | B – Blood and blood forming organs | C2-P6.17 | NO | ROMIPLOSTINUM | ROMIPLOSTIMUM | November 2025 | November 2025 | 1 | ||
| B02BX05 | ELTROMBOPAG | In force | B – Blood and blood forming organs | C2 -P6.17 | NO | ELTROMBOPAG | November 2025 | November 2025 | 1 | |||
| B02BX05-AAS | ELTROMBOPAG | In force | B – Blood and blood forming organs | C2-P3 | NO | ELTROMBOPAG | November 2025 | November 2025 | 1 | |||
| B02BX06 | EMICIZUMAB | In force | B – Blood and blood forming organs | C2-P6.27 | NO | EMICIZUMABUM | ARGININUM, TROMBINA | November 2025 | November 2025 | 1 | ||
| B02BX08 | AVATROMBOPAG | In force | B – Blood and blood forming organs | C2-P6.27/C1-G10 | NO | AVATROMBOPAG | INTERFERONUM | January 2026 | April 2026 · 2 versions | 2 | ||
| B03XA03 | EPOETINUM ZETA | In force | B – Blood and blood forming organs | C1-G25 si C2 -P10 | NO | EPOETINUM ZETA | November 2025 | November 2025 | 1 | |||
| B03XA03M | METOXI-POLIETILENGLICOL EPOETIN BETA | In force | B – Blood and blood forming organs | C1-G25 si C2 -P10 | NO | EPOETINUM BETA, METOXI-POLIETILENGLICOL EPOETINA BETA | November 2025 | November 2025 | 1 | |||
| B03XA06 | LUSPATERCEPT | In force | B – Blood and blood forming organs | C2 P6.1 | NO | LUSPATERCEPT | November 2025 | November 2025 | 1 | |||
| B03XA06-SMD | LUSPATERCEPT | In force | B – Blood and blood forming organs | C2-P3 | NO | LUSPATERCEPT | November 2025 | November 2025 | 1 | |||
| B06AC01 | INHIBITOR DE ESTERAZĂ C1, UMANĂ | In force | B – Blood and blood forming organs | C2-P6.22 | YES | DA, si initiere, pe baza scrisorii medicale eliberate de către Centrul de Expertiză de AEE | INHIBITOR DE ESTERAZA C1 | ICATIBANTUM | November 2025 | November 2025 | 1 | |
| B06AC02 | ICATIBANTUM | In force | B – Blood and blood forming organs | C2-P6.22 | YES | Da (si initiere pe baza scrisorii medicale de la Centrul de referinta/ Pilot de AEE) | ICATIBANTUM | November 2025 | November 2025 | 1 | ||
| B06AC04 | CONESTAT ALFA | In force | B – Blood and blood forming organs | C2-P6.22 | YES | DA(si initiere),pe baza scrisorii medicale eliberate de către Centrul de Expertiză de AEE. | CONESTAT | ICATIBANTUM | November 2025 | November 2025 | 1 | |
| B06AC05 | LANADELUMABUM | In force | B – Blood and blood forming organs | C2-P6.22 | YES | DA (si initiere),pe baza scrisorii medicale eliberate de către Centrul de Expertiză de AEE | LANADELUMABUM | ICATIBANTUM | November 2025 | November 2025 | 1 | |
| B06AC06 | BEROTRALSTATUM | In force | B – Blood and blood forming organs | C2-P6.22 | YES | DA, si initiere in baza scrisorii medicale eliberate de către Centrul de Expertiză de AEE | BEROTRALSTATUM | AMLODIPINUM, CICLOSPORINUM, DESOGESTRELUM, FENTANYLUM, ICATIBANTUM, MIDAZOLAMUM, RIFAMPICINUM | January 2026 | January 2026 | 1 | |
| BD01D | HEMOFILIA A si B si BOALA VON WILLEBRAND | In force | B – Blood and blood forming organs | C2-P6.1 | NO | CICLOSPORINUM, EMICIZUMABUM, FACTOR IX DE COAGULARE, FACTOR VIII DE COAGULARE, FACTOR VON WILLEBRAND … | CICLOSPORINUM, EMICIZUMABUM, FACTOR IX DE COAGULARE, FACTOR VIII DE COAGULARE, FACTOR VON WILLEBRAND, RITUXIMABUM, SUSOCTOCOG ALFA | November 2025 | November 2025 | 1 | ||
| C002I | ALPROSTADILUM | In force | C – Cardiovascular system | A | NO | ALPROSTADILUM | November 2025 | November 2025 | 1 | |||
| C003I | IVABRADINUM | In force | C – Cardiovascular system | B | YES | DA (si initiere) | IVABRADINUM | November 2025 | November 2025 | 1 | ||
| C004I | ACID OMEGA-3-ESTERI ETILICI | In force | C – Cardiovascular system | D | YES | ACID OMEGA-3-ESTERI ETILICI | November 2025 | November 2025 | 1 | |||
| C005I | SARTANI ÎN INSUFICIENŢA CARDIACĂ | In force | C – Cardiovascular system | C1-G1 | YES | ANGIOTENSINUM II, CANDESARTANUM CILEXETIL, VALSARTANUM | ANGIOTENSINUM II, CANDESARTANUM CILEXETIL, VALSARTANUM | November 2025 | November 2025 | 1 | ||
| C008N | IRBESARTANUM | In force | C – Cardiovascular system | C1-G25 | NO | IRBESARTANUM | November 2025 | November 2025 | 1 | |||
| C02KX02 | TAFAMIDIS | In force | C – Cardiovascular system | C2-P6.5.3 | NO | TAFAMIDIS | November 2025 | July 2026 · 2 versions | 2 | |||
| C03XA01 | TOLVAPTAN | In force | C – Cardiovascular system | C1-G25 | NO | TOLVAPTAN | ATAZANAVIRUM, DARUNAVIRUM, DILTIAZEMUM, FLUCONAZOLUM, IMATINIBUM, ITRACONAZOLUM, KETOCONAZOLUM, LOPINAVIRUM, MIFEPRISTONUM, NILOTINIBUM, POSACONAZOLUM, RITONAVIRUM, VASOPRESINUM, VERAPAMILUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | ||
| C07AA05 | PROPRANOLOLUM (soluție orală) | In force | C – Cardiovascular system | C3 | YES | PROPRANOLOLUM | November 2025 | November 2025 | 1 | |||
| C07FX05 | COMBINAȚII (METOPROLOLUM + IVABRADINUM) | In force | C – Cardiovascular system | B | YES | IVABRADINUM, METOPROLOLUM | AMIODARONUM, AMLODIPINUM, DILTIAZEMUM, ITRACONAZOLUM, KETOCONAZOLUM, RITONAVIRUM, VERAPAMILUM | November 2025 | November 2025 | 1 | ||
| C09BB02 | COMBINAȚII (ENALAPRILUM+LERCANIDIPINUM) | In force | C – Cardiovascular system | B | YES | DA(si initiere) | ENALAPRILUM, LERCANIDIPINUM | ANGIOTENSINUM II, CARBAMAZEPINUM, CICLOSPORINUM, RIFAMPICINUM, SACUBITRILUM, VALSARTANUM | November 2025 | November 2025 | 1 | |
| C09DB05 | COMBINAȚII (IRBESARTANUM+AMLODIPINUM) | In force | C – Cardiovascular system | B | YES | DA(si initiere) | AMLODIPINUM, IRBESARTANUM | November 2025 | November 2025 | 1 | ||
| C09DX04 | SACUBITRILUM/VALSARTANUM | In force | C – Cardiovascular system | C1-G1 | YES | SACUBITRILUM, VALSARTANUM | November 2025 | November 2025 | 1 | |||
| C10AX06 | ICOSAPENT ETHYL | In force | C – Cardiovascular system | A | YES | ICOSAPENT ETHYL | April 2026 | April 2026 | 1 | |||
| C10AX13 | EVOLOCUMAB | In force | C – Cardiovascular system | C1-G22 | YES | EVOLOCUMABUM | November 2025 | April 2026 · 2 versions | 2 | |||
| C10AX14 | ALIROCUMABUM | In force | C – Cardiovascular system | C1-G22 | YES | ALIROCUMABUM | November 2025 | April 2026 · 2 versions | 2 | |||
| C10AX16 | INCLISIRAN | In force | C – Cardiovascular system | C1-G22 | YES | DA, in baza scrisorii medicale | INCLISIRAN | EZETIMIBUM | January 2026 | March 2026 · 2 versions | 2 | |
| C10AX18 | VOLANESORSENUM | In force | C – Cardiovascular system | C1-G22 | NO | VOLANESORSENUM | April 2026 | April 2026 | 1 | |||
| C10BA05 | COMBINAŢII (EZETIMIBUM + ATORVASTATINUM) | In force | C – Cardiovascular system | B | YES | DA (si initiere) | ATORVASTATINUM, EZETIMIBUM | GLECAPREVIRUM, PIBRENTASVIRUM | November 2025 | November 2025 | 1 | |
| C10BA06 | COMBINAȚII (ROSUVASTATINUM + EZETIMIBUM) | In force | C – Cardiovascular system | B | YES | DA (si initiere) | EZETIMIBUM, ROSUVASTATINUM | ATAZANAVIRUM, CICLOSPORINUM, LOPINAVIRUM, RITONAVIRUM | November 2025 | November 2025 | 1 | |
| C10BX13 | COMBINAŢII (ROSUVASTATINUM + PERINDOPRILUM + INDAPAMIDUM) | In force | C – Cardiovascular system | B | YES | DA (si initiere) | INDAPAMIDUM, PERINDOPRILUM, ROSUVASTATINUM | ATAZANAVIRUM, CICLOSPORINUM, LOPINAVIRUM, RITONAVIRUM | November 2025 | November 2025 | 1 | |
| CI01I | BOSENTANUM | In force | C – Cardiovascular system | C2-P6.16 | NO | BOSENTANUM | CICLOSPORINUM, NIFEDIPINUM | November 2025 | November 2025 | 1 | ||
| CI01I-HTP | Protocol terapeutic în hipertensiunea arterială pulmonară: SILDENAFILUM, BOSENTANUM, AMBRISENTANUM, MACITENTANUM, RIOCIGUAT | In force | C – Cardiovascular system | C2-P6.3 | NO | AMBRISENTANUM, BOSENTANUM, MACITENTANUM, RIOCIGUAT, SILDENAFILUM | CICLOSPORINUM, ILOPROSTUM, SELEXIPAGUM, TADALAFILUM, TREPROSTINILUM | November 2025 | April 2026 · 2 versions | 2 | ||
| D002L | ACITRETINUM | In force | D – Dermatologicals | B | NO | ACITRETINUM | November 2025 | November 2025 | 1 | |||
| D11AH-L04AA | DERMATITA ATOPICĂ - AGENŢI BIOLOGICI: DUPILUMABUM**1Ω ȘI INHIBITORI DE JAK: BARICITINIBUM**1Ω, UPADACITINIBUM (15 mg, 30 mg)**1Ω, ABROCITINIBUM**1Ω | In force | D – Dermatologicals | C1-G31G | NO | ABROCITINIBUM, BARICITINIBUM, DUPILUMABUM, UPADACITINIBUM | APALUTAMIDUM, CICLOSPORINUM, EFAVIRENZUM, ENZALUTAMIDUM, FLUCONAZOLUM, FLUOXETINUM, FLUVOXAMINUM, RIFAMPICINUM, TICLOPIDINUM, TUBERCULINUM | November 2025 | January 2026 · 2 versions | 2 | ||
| D11AH05-A | DUPILUMABUM | In force | D – Dermatologicals | C1-G31H | YES | DA, în baza scrisorii medicale transmisa de medicul care a initiat tratamentul, in dozele si pe durata prevazuta in aceasta | DUPILUMABUM | BUDESONIDUM, CICLESONIDUM, TRIAMCINOLONUM | November 2025 | July 2026 · 3 versions | 3 | |
| D11AH05-BPOC | DUPILUMABUM | In force | D – Dermatologicals | C1-G31H | YES | DA, in baza scrisorii medicale | DUPILUMABUM | January 2026 | July 2026 · 2 versions | 2 | ||
| D11AH05-PN | DUPILUMABUM | In force | D – Dermatologicals | C1-G31G | NO | DUPILUMABUM | CICLOSPORINUM, PIMECROLIMUS, TACROLIMUSUM, TALIDOMIDUM | January 2026 | January 2026 | 1 | ||
| G001C | CABERGOLINUM | In force | G – Genito-urinary system and sex hormones | C1-G22 | YES | CABERGOLINUM | BROMOCRIPTINUM, ESTRADIOLUM, SOMATOSTATINUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | ||
| G002N | ESTRADIOLUM VALERAT + DIENOGEST | In force | G – Genito-urinary system and sex hormones | B | YES | DIENOGESTUM, ESTRADIOLUM VALERAT | CYPROTERONUM, PROGESTERONUM | November 2025 | November 2025 | 1 | ||
| G003N | FOLLITROPINUM ALFA | In force | G – Genito-urinary system and sex hormones | B | NO | November 2025 | November 2025 | 1 | ||||
| G004N | GANIRELIXUM | In force | G – Genito-urinary system and sex hormones | B | NO | GANIRELIXUM | ESTRADIOLUM | November 2025 | November 2025 | 1 | ||
| G005N | LEVONORGESTRELUM | In force | G – Genito-urinary system and sex hormones | B | NO | LEVONORGESTRELUM | November 2025 | November 2025 | 1 | |||
| G006N | LUTROPINA ALFA | In force | G – Genito-urinary system and sex hormones | B | NO | LUTROPINA, LUTROPINUM ALFA | CLOMIFENUM, ESTRADIOLUM, HEPARINUM, NICOTINUM, PROGESTERONUM, SOMATOSTATINUM, SULFASALAZINUM | November 2025 | November 2025 | 1 | ||
| G007N | TIBOLONUM | In force | G – Genito-urinary system and sex hormones | B | YES | TIBOLONUM | November 2025 | November 2025 | 1 | |||
| G008N | FOLLITROPINUM BETA | In force | G – Genito-urinary system and sex hormones | B | NO | FOLLITROPINUM BETA | ESTRADIOLUM | November 2025 | November 2025 | 1 | ||
| G009N | SOLIFENACINUM SUCCINAT | In force | G – Genito-urinary system and sex hormones | B | YES | SOLIFENACINUM SUCCINATE | ITRACONAZOLUM, KETOCONAZOLUM, RITONAVIRUM | November 2025 | November 2025 | 1 | ||
| G010N | TOLTERODINUM/SOLIFENACINUM | In force | G – Genito-urinary system and sex hormones | B | * | * | SOLIFENACINUM SUCCINATE, TOLTERODINUM | November 2025 | November 2025 | 1 | ||
| H003N | CINACALCET HIDROCLORID | In force | H – Systemic hormonal preparations | C2-P10 | NO | CINACALCETUM | ALFACALCIDOLUM, CALCITRIOLUM | November 2025 | November 2025 | 1 | ||
| H004E | CETRORELIXUM | In force | H – Systemic hormonal preparations | B | NO | CETRORELIXUM | ESTRADIOLUM, HEPARINUM, NICOTINUM, PROGESTERONUM, SULFASALAZINUM | November 2025 | November 2025 | 1 | ||
| H005E | PROTOCOL TERAPEUTIC ÎN ACROMEGALIE ŞI GIGANTISM | In force | H – Systemic hormonal preparations | C1-G22 | YES | BROMOCRIPTINUM, CABERGOLINUM, ESTRADIOLUM, LANREOTIDUM, OCTREOTIDUM … | BROMOCRIPTINUM, CABERGOLINUM, ESTRADIOLUM, LANREOTIDUM, OCTREOTIDUM, PASIREOTIDUM, PEGVISOMANTUM, SOMATOSTATINUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | ||
| H006C | TUMORI NEUROENDOCRINE - TRATAMENT CU ANALOGI DE SOMATOSTATINĂ | In force | H – Systemic hormonal preparations | C1-G22 | NO | SOMATOSTATINUM | CAPECITABINUM, GLUCAGONUM, INTERFERONUM, IRINOTECANUM, LANREOTIDUM, LUTETIUM, OCTREOTIDUM, OXALIPLATINUM, TEMOZOLOMIDUM | November 2025 | November 2025 | 1 | ||
| H006E | SOMATROPINUM LA COPII, ÎN PERIOADA DE TRANZIŢIE ȘI LA ADULȚI CU DEFICIT AL HORMONULUI DE CREȘTERE | In force | H – Systemic hormonal preparations | A | NO | SOMATROPINUM | ARGININUM, CLONIDINUM, DOPAMINUM, ESTRADIOLUM, GLUCAGONUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | ||
| H011Q | SOMATROPINUM | In force | H – Systemic hormonal preparations | C2-P6.7 | NO | November 2025 | November 2025 | 1 | ||||
| H01AC03 | MECASERMINUM | In force | H – Systemic hormonal preparations | C3 | NO | MECASERMINUM | AMINOACIZI, ARGININUM, CLONIDINUM, GLUCAGONUM, SOMATROPINUM | November 2025 | November 2025 | 1 | ||
| H01CB05 | PASIREOTIDUM | In force | H – Systemic hormonal preparations | C1-G22 | NO | PASIREOTIDUM | November 2025 | November 2025 | 1 | |||
| H02CA02 | OSILODROSTATUM | In force | H – Systemic hormonal preparations | C1-G22 | NO | OSILODROSTATUM | AMIODARONUM, AMISULPRIDUM, ATORVASTATINUM, CAFEINUM, CARBAMAZEPINUM, CITALOPRAMUM, DILTIAZEMUM, ITRACONAZOLUM, KETOCONAZOLUM, RIFAMPICINUM, RITONAVIRUM, VERAPAMILUM | April 2026 | April 2026 | 1 | ||
| H05AA02 | TERIPARATIDUM | In force | H – Systemic hormonal preparations | C1-G22 | NO | November 2025 | November 2025 | 1 | ||||
| H05AA03 | PARATHYROID HORMONE | In force | H – Systemic hormonal preparations | C1-G22 | NO | CALCITRIOLUM, CICLOSPORINUM, DIAZEPAMUM | CALCITRIOLUM, CICLOSPORINUM, DIAZEPAMUM | November 2025 | November 2025 | 1 | ||
| J001G | IMUNOGLOBULINĂ NORMALĂ PENTRU ADMINISTRARE INTRAVASCULARĂ | In force | J – Anti-infectives for systemic use | C2- P6.5.1, P6.15, P9.1, P9.4 | NO | ADRENALINUM, IBUPROFENUM, PARACETAMOLUM | ADRENALINUM, IBUPROFENUM, PARACETAMOLUM | November 2025 | November 2025 | 1 | ||
| J002N | RIBAVIRINUM | In force | J – Anti-infectives for systemic use | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO | RIBAVIRINUM | November 2025 | November 2025 | 1 | |||
| J003N | PEGINTERFERONUM ALFA 2B | In force | J – Anti-infectives for systemic use | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO | PEGINTERFERONUM | November 2025 | November 2025 | 1 | |||
| J004N | PEGINTERFERONUM ALFA 2A | In force | J – Anti-infectives for systemic use | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO | PEGINTERFERON ALFA-2A, PEGINTERFERONUM | November 2025 | November 2025 | 1 | |||
| J005N | LAMIVUDINUM | In force | J – Anti-infectives for systemic use | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO | LAMIVUDINUM | ADEFOVIRUM, ENTECAVIRUM | November 2025 | November 2025 | 1 | ||
| J006N | INTERFERONUM ALFA 2B | In force | J – Anti-infectives for systemic use | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO | INTERFERONUM | November 2025 | November 2025 | 1 | |||
| J007N | INTERFERONUM ALFA 2A | In force | J – Anti-infectives for systemic use | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO | INTERFERONUM | November 2025 | November 2025 | 1 | |||
| J008N | ENTECAVIRUM | In force | J – Anti-infectives for systemic use | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO | ENTECAVIRUM | ADEFOVIRUM, DIPIVOXILUM, LAMIVUDINUM | November 2025 | November 2025 | 1 | ||
| J009N | ADEFOVIRUM DIPIVOXILUM | In force | J – Anti-infectives for systemic use | C1-G4 si G7 doar pentru pacienţii cu afectare renală consecutivă infecţiei cu virusuri hepatitice | NO | ADEFOVIRUM, DIPIVOXILUM | ENTECAVIRUM | November 2025 | November 2025 | 1 | ||
| J010D | CASPOFUNGINUM | In force | J – Anti-infectives for systemic use | C1-G10, C2 - P9 | * | * | CASPOFUNGINUM | November 2025 | November 2025 | 1 | ||
| J012B | VORICONAZOLUM | In force | J – Anti-infectives for systemic use | C1-G10, C2 - P9 | * | * | VORICONAZOLUM | November 2025 | November 2025 | 1 | ||
| J01XB01 | COLISTIMETAT DE SODIU | In force | J – Anti-infectives for systemic use | C2-P6.4 | YES | COLISTIMETAT | CIPROFLOXACINUM, COLISTINUM, NORFLOXACINUM | November 2025 | November 2025 | 1 | ||
| J02AB02 | KETOCONAZOLUM (comprimate 200 MG) | In force | J – Anti-infectives for systemic use | C1-G22 | NO | KETOCONAZOLUM | PARACETAMOLUM, PASIREOTIDUM | November 2025 | November 2025 | 1 | ||
| J02AC05 | ISAVUCONAZOLUM | In force | J – Anti-infectives for systemic use | A forme orale,C1-G10-forme orale,C2- P9.1-P9.6, P9.7-forme orale, C3-forme orale | YES | DA, pentru formele cu administrare orala | ISAVUCONAZOLUM | CARBAMAZEPINUM, EFAVIRENZUM, ETRAVIRINUM, KETOCONAZOLUM, RIFAMPICINUM, RITONAVIRUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | |
| J05AP | Hepatită cronică şi Ciroză hepatică cu VHC, cu medicamente cu acțiune antivirală directă (interferon-free) | In force | J – Anti-infectives for systemic use | C1-G4 si G7 | NO | INTERFERONUM | GLECAPREVIRUM, PIBRENTASVIRUM, RIBAVIRINUM, SOFOSBUVIRUM, VELPATASVIRUM | November 2025 | November 2025 | 1 | ||
| J05AP56 | SOFOSBUVIRUM+VELPATASVIRUM+VOXILAPREVIRUM | In force | J – Anti-infectives for systemic use | C1-G4 si G7 | NO | SOFOSBUVIRUM, VELPATASVIRUM, VOXILAPREVIRUM | November 2025 | November 2025 | 1 | |||
| J05AX18 | LETERMOVIRUM (forma orală) | In force | J – Anti-infectives for systemic use | C2-P9.1, P9.7 | YES | DA, in P9.7 in baza scrisorii medicale emise de medicul specialist din centrele acreditate pentru activitatea de transplant medular | LETERMOVIRUM | ATORVASTATINUM, CICLOSPORINUM, ROSUVASTATINUM, SIMVASTATINUM, SIROLIMUS, TACROLIMUSUM, VORICONAZOLUM | November 2025 | March 2026 · 2 versions | 2 | |
| J05AX28 | BULEVIRTIDUM | In force | J – Anti-infectives for systemic use | C1-G4 si G7 | NO | BULEVIRTIDUM | AMINOACIZI, INTERFERONUM, PEGINTERFERONUM | November 2025 | July 2026 · 2 versions | 2 | ||
| J06BA01 | IMUNOGLOBULINA UMANA NORMALA | In force | J – Anti-infectives for systemic use | C2- P6.5.1, P6.15, P9.1, P9.4 | NO | November 2025 | November 2025 | 1 | ||||
| J06BA01-PDIC | IMUNOGLOBULINA UMANĂ NORMALĂ | In force | J – Anti-infectives for systemic use | C2-P6.5.1 | NO | IMUNOGLOBULINA UMANA NORMALA | PARACETAMOLUM, VACCIN RUJEOLIC | November 2025 | November 2025 | 1 | ||
| J06BB16 | PALIVIZUMABUM | In force | J – Anti-infectives for systemic use | C3 | YES | PALIVIZUMABUM | TERIPARATIDUM | November 2025 | November 2025 | 1 | ||
| J07AH08-09 | VACCIN MENINGOCOCIC | In force | J – Anti-infectives for systemic use | E-E2 | YES | DA(si initiere) | November 2025 | November 2025 | 1 | |||
| J07AJ52 | VACCIN DIFTERO-TETANO-PERTUSSIS ACELULAR | In force | J – Anti-infectives for systemic use | E-E2 | YES | DA(si initiere) | VACCIN DIFTERO-TETANO-PERTUSSIS ACELULAR | November 2025 | November 2025 | 1 | ||
| J07AL02 | VACCIN PNEUMOCOCIC POLIZAHARIDIC | In force | J – Anti-infectives for systemic use | E-E2 | YES | DA(si initiere) | VACCIN PNEUMOCOCIC POLIZAHARIDIC | VACCIN PNEUMOCOCIC POLIZAHARIDIC CONJUGAT | November 2025 | November 2025 | 1 | |
| J07BB02-03 | VACCIN GRIPAL | In force | J – Anti-infectives for systemic use | E-E1 si E2 | YES | DA(si initiere) | GELATINUM, GENTAMICINUM, INTERFERONUM, NEOMICINUM | GELATINUM, GENTAMICINUM, INTERFERONUM, NEOMICINUM | November 2025 | November 2025 | 1 | |
| J07BC01 | VACCIN HEPATITIC B | In force | J – Anti-infectives for systemic use | E-E2 | YES | DA(si initiere) | VACCIN HEPATITIC B | November 2025 | November 2025 | 1 | ||
| J07BD52 | VACCIN RUJEOLIC, RUBEOLIC, URLIAN (ROR) | In force | J – Anti-infectives for systemic use | E-E2 | YES | DA(si initiere) | VACCIN RUJEOLIC | NEOMICINUM, PREDNISONUM, TUBERCULINUM | November 2025 | November 2025 | 1 | |
| J07BK01 | VACCIN VARICELIC VIU ATENUAT | In force | J – Anti-infectives for systemic use | E-E2 | YES | DA(si initiere) | VACCIN VARICELIC VIU ATENUAT | November 2025 | November 2025 | 1 | ||
| J07BM03 | VACCIN PAPILOMAVIRUS | In force | J – Anti-infectives for systemic use | E-E1 si E2 | YES | DA(si initiere) | VACCIN PAPILOMAVIRUS | November 2025 | November 2025 | 1 | ||
| L001C | ACIDUM CLODRONICUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | ACIDUM CLODRONICUM | November 2025 | November 2025 | 1 | ||
| L001G | MITOXANTRONUM | In force | L – Antineoplastic and immunomodulating agents | C1-G14 | * | * | MITOXANTRONUM | November 2025 | November 2025 | 1 | ||
| L002G | SCLEROZA MULTIPLĂ - TRATAMENT IMUNOMODULATOR | In force | L – Antineoplastic and immunomodulating agents | C2-P4 | NO | ACICLOVIRUM, ALEMTUZUMABUM, AMIODARONUM, CLADRIBINUM, DESLORATADINUM … | ACICLOVIRUM, ALEMTUZUMABUM, AMIODARONUM, CLADRIBINUM, DESLORATADINUM, DILTIAZEMUM, DIMETHYL FUMARATE, FINGOLIMODUM, GLATIRAMER ACETAT, IBUPROFENUM, INTERFERONUM BETA, NAPROXENUM, NATALIZUMABUM, OCRELIZUMABUM, OFATUMUMABUM, OZANIMODUM, PARACETAMOLUM, PEGINTERFERON BETA-1A, PEGINTERFERONUM, SIPONIMOD, SOTALOLUM, TERIFLUNOMIDUM, VERAPAMILUM | November 2025 | March 2026 · 2 versions | 2 | ||
| L004C | BEVACIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | BEVACIZUMABUM | CAPECITABINUM, CARBOPLATINUM, CISPLATINUM, DOXORUBICINUM, GEMCITABINUM, INTERFERONUM, PACLITAXELUM, TOPOTECANUM | November 2025 | November 2025 | 1 | ||
| L008C | IMATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | IMATINIBUM | INTERFERONUM | November 2025 | March 2026 · 2 versions | 2 | |
| L012C | BORTEZOMIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | BORTEZOMIBUM | PREDNISONUM, SOMATROPINUM | November 2025 | November 2025 | 1 | ||
| L014AE | FIBROZA PULMONARĂ IDIOPATICĂ | In force | L – Antineoplastic and immunomodulating agents | C2-P6.20 | NO | CICLOSPORINUM, FLUVOXAMINUM, KETOCONAZOLUM, NINTEDANIBUM, PIRFENIDONUM | CICLOSPORINUM, FLUVOXAMINUM, KETOCONAZOLUM, NINTEDANIBUM, PIRFENIDONUM | November 2025 | November 2025 | 1 | ||
| L014C | RITUXIMABUM (original si biosimilar) | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | RITUXIMABUM | FIBRINOGEN, VENETOCLAX | November 2025 | November 2025 | 1 | ||
| L015D | ANAGRELIDUM | In force | L – Antineoplastic and immunomodulating agents | C1-G10 | NO | ANAGRELIDUM | November 2025 | November 2025 | 1 | |||
| L016C | INTERFERON ALFA 2B | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | INTERFERONUM | November 2025 | November 2025 | 1 | |||
| L01AA09 | BENDAMUSTINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | BENDAMUSTINUM | ACICLOVIRUM, CICLOSPORINUM, CIMETIDINUM, CIPROFLOXACINUM, FLUDARABINUM, FLUVOXAMINUM, TACROLIMUSUM | November 2025 | November 2025 | 1 | ||
| L01BB06 | CLOFARABINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | CLOFARABINUM | November 2025 | November 2025 | 1 | |||
| L01BB07 | NELARABINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | NELARABINUM | November 2025 | November 2025 | 1 | |||
| L01BC07 | AZACITIDINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | AZACITIDINUM | November 2025 | November 2025 | 1 | |||
| L01BC08 | DECITABINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | DECITABINUM | November 2025 | November 2025 | 1 | |||
| L01BC59 | COMBINATI (TRIFLURIDINUM + TIPIRACILUM) | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TIPIRACILUM, TRIFLURIDINUM | BEVACIZUMABUM, IRINOTECANUM, OXALIPLATINUM | November 2025 | November 2025 | 1 | ||
| L01CD01 | PACLITAXELUM (concentrația 5 mg/ml) | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | PACLITAXELUM | ATEZOLIZUMAB, GEMCITABINUM, PEMBROLIZUMABUM | November 2025 | November 2025 | 1 | ||
| L01CD04 | CABAZITAXELUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | CABAZITAXELUM | DOCETAXELUM, PREDNISOLONUM, PREDNISONUM | November 2025 | November 2025 | 1 | ||
| L01CX01 | TRABECTEDINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TRABECTEDINUM | DOXORUBICINUM, IFOSFAMIDUM | November 2025 | November 2025 | 1 | ||
| L01EA06 | ASCIMINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii de familie desemnati | ASCIMINIBUM | November 2025 | July 2026 · 2 versions | 2 | ||
| L01EC03-FE01 | ENCORAFENIBUM+ CETUXIMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI | CETUXIMABUM, ENCORAFENIBUM | April 2026 | April 2026 | 1 | ||
| L01ED04 | BRIGATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | BRIGATINIBUM | CRIZOTINIBUM | November 2025 | November 2025 | 1 | ||
| L01EE02-EC01 | COBIMETINIBUM + VEMURAFENIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI | COBIMETINIBUM, VEMURAFENIBUM | April 2026 | April 2026 | 1 | ||
| L01EE03-EC03 | BINIMETINIBUM + ENCORAFENIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI | BINIMETINIBUM, ENCORAFENIBUM | April 2026 | April 2026 | 1 | ||
| L01EE04 | SELUMETINIB | In force | L – Antineoplastic and immunomodulating agents | C1-G12 | NO | SELUMETINIBUM | CARBAMAZEPINUM, FLUCONAZOLUM, KETOCONAZOLUM, OMEPRAZOLUM, RIFAMPICINUM, TICLOPIDINUM | November 2025 | March 2026 · 2 versions | 2 | ||
| L01EH03 | TUCATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TUCATINIBUM | CAPECITABINUM, CARBAMAZEPINUM, ITRACONAZOLUM, METFORMINUM, RIFAMPICINUM, TRASTUZUMABUM | November 2025 | November 2025 | 1 | ||
| L01EJ02 | FEDRATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | FEDRATINIBUM | RUXOLITINIBUM | November 2025 | November 2025 | 1 | ||
| L01EK03 | TIVOZANIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | TIVOZANIBUM | INTERFERONUM | November 2025 | November 2025 | 1 | |
| L01EL02 | ACALABRUTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | ACALABRUTINIBUM | BENDAMUSTINUM, FLUDARABINUM, OBINUTUZUMABUM, RITUXIMABUM, VENETOCLAX | November 2025 | July 2026 · 3 versions | 3 | ||
| L01EL03 | ZANUBRUTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | ZANUBRUTINIBUM | FLUDARABINUM, RITUXIMABUM | January 2026 | April 2026 · 2 versions | 2 | ||
| L01EM03 | ALPELISIB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI | ALPELISIB | DENOSUMABUM, FULVESTRANTUM, METFORMINUM | April 2026 | April 2026 | 1 | |
| L01EN02 | PEMIGATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI | PEMIGATINIBUM | April 2026 | April 2026 | 1 | ||
| L01EX14 | ENTRECTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI | ENTRECTINIBUM | April 2026 | April 2026 | 1 | ||
| L01EX18 | AVAPRITINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI PENTRU GIST | AVAPRITINIBUM | April 2026 | April 2026 | 1 | ||
| L01EX19 | RIPRETINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI | RIPRETINIBUM | IMATINIBUM, ITRACONAZOLUM, REGORAFENIBUM, RIFAMPICINUM, SUNITINIBUM | April 2026 | April 2026 | 1 | |
| L01EX22 | SELPERCATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | SELPERCATINIBUM | CABOZANTINIBUM, VANDETANIBUM | January 2026 | July 2026 · 2 versions | 2 | |
| L01FA01 | RITUXIMABUM | In force | L – Antineoplastic and immunomodulating agents | C1-G27 | NO | RITUXIMABUM | OXIGENUM, PARACETAMOLUM, PREDNISONUM, RIFAMPICINUM, TUBERCULINUM | November 2025 | November 2025 | 1 | ||
| L01FD04 | TRASTUZUMABUM DERUXTECANUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TRASTUZUMABUM DERUXTECANUM | ITRACONAZOLUM, PREDNISOLONUM, RITONAVIRUM, TIPIRACILUM, TRIFLURIDINUM | November 2025 | November 2025 | 1 | ||
| L01FF-L01EX | NIVOLUMABUM + DCI CABOZANTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | CABOZANTINIBUM, NIVOLUMABUM | PREDNISONUM | November 2025 | November 2025 | 1 | ||
| L01FX02 | GEMTUZUMAB OZOGAMICIN | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | GEMTUZUMAB OZOGAMICIN | DAUNORUBICINUM, DEXTRANUM, PARACETAMOLUM | November 2025 | November 2025 | 1 | ||
| L01FX09 | MOGAMULIZUMAB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | MOGAMULIZUMAB | November 2025 | November 2025 | 1 | |||
| L01FX12 | TAFASITAMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TAFASITAMABUM | CIMETIDINUM, LENALIDOMIDUM, PARACETAMOLUM | April 2026 | April 2026 | 1 | ||
| L01FX17 | SACITUZUMAB GOVITECAN | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | SACITUZUMAB GOVITECAN | ATROPINUM, CARBAMAZEPINUM, KETOCONAZOLUM, LOPERAMIDUM, PROPOFOLUM, RIFAMPICINUM, RITONAVIRUM | November 2025 | November 2025 | 1 | ||
| L01FX18 | AMIVANTAMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | AMIVANTAMABUM | April 2026 | April 2026 | 1 | |||
| L01FX20 | TREMELIMUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TREMELIMUMABUM | DURVALUMABUM, ENTECAVIRUM | April 2026 | April 2026 | 1 | ||
| L01FX25 | MOSUNETUZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | MOSUNETUZUMABUM | ECULIZUMABUM, OXIGENUM, PARACETAMOLUM, TOCILIZUMABUM, VASOPRESINUM | November 2025 | November 2025 | 1 | ||
| L01XC-L04AJ | VASCULITE ANCA POZITIVE - DCI RITUXIMABUM**1 (original și biosimilar) și DCI AVACOPAN**1Ω | In force | L – Antineoplastic and immunomodulating agents | C1-G17 | NO | AVACOPAN, RITUXIMABUM | INTERFERONUM, KETOCONAZOLUM, PARACETAMOLUM, PREDNISOLONUM, PREDNISONUM, RIFAMPICINUM, SIROLIMUS, TACROLIMUSUM, TUBERCULINUM | April 2026 | July 2026 · 2 versions | 2 | ||
| L01XC02 | RITUXIMABUM | In force | L – Antineoplastic and immunomodulating agents | C1-G17 | NO | RITUXIMABUM | INTERFERONUM, PARACETAMOLUM, PREDNISOLONUM, PREDNISONUM, TUBERCULINUM | November 2025 | November 2025 | 1 | ||
| L01XC08 | PANITUMUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | PANITUMUMABUM | IRINOTECANUM, OXALIPLATINUM | November 2025 | November 2025 | 1 | ||
| L01XC11 | IPILIMUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | IPILIMUMABUM | LOPERAMIDUM, PREDNISONUM | November 2025 | November 2025 | 1 | ||
| L01XC11-17 | NIVOLUMABUM + DCI IPILIMUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | IPILIMUMABUM, NIVOLUMABUM | IRINOTECANUM, LOPERAMIDUM, OXALIPLATINUM, PREDNISONUM | November 2025 | April 2026 · 2 versions | 2 | ||
| L01XC12 | BRENTUXIMAB VEDOTIN | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | BRENTUXIMAB VEDOTIN | DACARBAZINUM, DOXORUBICINUM, ETOPOSIDUM, PREDNISONUM, VINBLASTINUM | November 2025 | July 2026 · 2 versions | 2 | ||
| L01XC13 | PERTUZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | PERTUZUMABUM | DOCETAXELUM, PACLITAXELUM, TRASTUZUMABUM | November 2025 | November 2025 | 1 | ||
| L01XC14 | TRASTUZUMAB EMTANSINE | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TRASTUZUMABUM, TRASTUZUMABUM EMTANSINUM | November 2025 | November 2025 | 1 | |||
| L01XC15 | OBINUTUZUMAB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | OBINUTUZUMABUM | BENDAMUSTINUM, DOXORUBICINUM, FLUDARABINUM, PARACETAMOLUM, PREDNISOLONUM, PREDNISONUM, RITUXIMABUM, VINCRISTINUM | November 2025 | November 2025 | 1 | ||
| L01XC16 | DINUTUXIMAB BETA | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | DINUTUXIMAB BETA | ADRENALINUM, GABAPENTINUM, IBUPROFENUM, PARACETAMOLUM, PREDNISOLONUM, TRAMADOLUM | November 2025 | November 2025 | 1 | ||
| L01XC17 | NIVOLUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | NIVOLUMABUM | BRENTUXIMAB VEDOTIN, CISPLATINUM, FIBRINOGEN, IPILIMUMABUM, LOPERAMIDUM, PREDNISONUM | November 2025 | July 2026 · 2 versions | 2 | ||
| L01XC18 | PEMBROLIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | PEMBROLIZUMABUM | AXITINIBUM, BEVACIZUMABUM, CARBOPLATINUM, CISPLATINUM, FLUOROURACILUM, IRINOTECANUM, OXALIPLATINUM, PACLITAXELUM, PEMETREXEDUM, PREDNISONUM | November 2025 | July 2026 · 2 versions | 2 | ||
| L01XC19 | BLINATUMOMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | BLINATUMOMABUM | PARACETAMOLUM, PREDNISONUM | November 2025 | July 2026 · 2 versions | 2 | ||
| L01XC21 | RAMUCIRUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | RAMUCIRUMABUM | DOCETAXELUM, ERLOTINIBUM, PACLITAXELUM, PARACETAMOLUM, SORAFENIBUM | November 2025 | November 2025 | 1 | ||
| L01XC24 | DARATUMUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | DARATUMUMABUM | BORTEZOMIBUM, LENALIDOMIDUM, MONTELUKASTUM, PARACETAMOLUM, POMALIDOMIDUM, PREDNISONUM, TALIDOMIDUM | November 2025 | July 2026 · 2 versions | 2 | ||
| L01XC26 | INOTUZUMAB OZOGAMICIN | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | INOTUZUMAB OZOGAMICIN | VINCRISTINUM | November 2025 | November 2025 | 1 | ||
| L01XC28 | DURVALUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | DURVALUMABUM | CARBOPLATINUM, CISPLATINUM, GEMCITABINUM, PACLITAXELUM, PREDNISONUM | November 2025 | March 2026 · 3 versions | 3 | ||
| L01XC31 | AVELUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | AVELUMABUM | AXITINIBUM, NIVOLUMABUM, PARACETAMOLUM, PEMBROLIZUMABUM, PREDNISONUM | November 2025 | November 2025 | 1 | ||
| L01XC32 | ATEZOLIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | ATEZOLIZUMAB | BEVACIZUMABUM, CARBOPLATINUM, CISPLATINUM, ENTECAVIRUM, ETOPOSIDUM, PACLITAXELUM, PREDNISONUM, PROGESTERONUM | November 2025 | November 2025 | 1 | ||
| L01XC33 | CEMIPLIMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | CEMIPLIMABUM | PREDNISONUM | November 2025 | November 2025 | 1 | ||
| L01XC37 | POLATUZUMAB VEDOTIN | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | POLATUZUMAB VEDOTIN | BENDAMUSTINUM, DAUNORUBICINUM, DOXORUBICINUM, EPIRUBICINUM, IDARUBICINUM, PREDNISONUM, RITUXIMABUM | November 2025 | November 2025 | 1 | ||
| L01XC38 | ISATUXIMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | ISATUXIMABUM | CARFILZOMIBUM, CETIRIZINUM, CIMETIDINUM, ESOMEPRAZOLUM, LENALIDOMIDUM, MONTELUKASTUM, OMEPRAZOLUM, PARACETAMOLUM, POMALIDOMIDUM | January 2026 | April 2026 · 2 versions | 2 | ||
| L01XE02 | GEFITINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P 3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | GEFITINIBUM | CARBAMAZEPINUM, RIFAMPICINUM | November 2025 | November 2025 | 1 | |
| L01XE06 | DASATINIB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | DASATINIBUM | IMATINIBUM | November 2025 | November 2025 | 1 | |
| L01XE07 | LAPATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | LAPATINIBUM | CAPECITABINUM, LETROZOLUM, PROGESTERONUM, TRASTUZUMABUM | November 2025 | November 2025 | 1 | |
| L01XE08 | NILOTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | NILOTINIBUM | IMATINIBUM | November 2025 | November 2025 | 1 | |
| L01XE10 | EVEROLIMUS (VOTUBIA) | In force | L – Antineoplastic and immunomodulating agents | C2-P6.19 | NO | EVEROLIMUS | SIROLIMUS | November 2025 | November 2025 | 1 | ||
| L01XE10A | EVEROLIMUS | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, medicii de familie desemnati | EVEROLIMUS | EXEMESTANUM, PREDNISONUM, SIROLIMUS, TEMSIROLIMUSUM | November 2025 | January 2026 · 2 versions | 2 | |
| L01XE11 | PAZOPANIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | PAZOPANIBUM | BEVACIZUMABUM, SORAFENIBUM, SUNITINIBUM | November 2025 | November 2025 | 1 | |
| L01XE12 | VANDETANIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | VANDETANIBUM | ACENOCUMAROLUM, AMIODARONUM, CARBAMAZEPINUM, MOXIFLOXACINUM, RIFAMPICINUM, SOTALOLUM, TOREMIFENUM | November 2025 | November 2025 | 1 | ||
| L01XE13 | AFATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | AFATINIBUM | LOPERAMIDUM | November 2025 | March 2026 · 2 versions | 2 | |
| L01XE14 | BOSUTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | BOSUTINIBUM | DASATINIBUM, IMATINIBUM, NILOTINIBUM | November 2025 | November 2025 | 1 | |
| L01XE15 | VEMURAFENIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | VEMURAFENIBUM | AMIODARONUM, CARBAMAZEPINUM, CICLOSPORINUM, DABIGATRANUM ETEXILATUM, DIGOXINUM, DULOXETINUM, IPILIMUMABUM, ITRACONAZOLUM, MELATONINUM, RANOLAZINUM, RIFAMPICINUM, RITONAVIRUM, VERAPAMILUM | November 2025 | November 2025 | 1 | |
| L01XE16 | CRIZOTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | CRIZOTINIBUM | November 2025 | November 2025 | 1 | ||
| L01XE17 | AXITINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | AXITINIBUM | SUNITINIBUM | November 2025 | November 2025 | 1 | |
| L01XE18 | RUXOLITINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | RUXOLITINIBUM | FLUCONAZOLUM | November 2025 | November 2025 | 1 | |
| L01XE21 | REGORAFENIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | REGORAFENIBUM | IMATINIBUM, SORAFENIBUM, SUNITINIBUM | November 2025 | March 2026 · 3 versions | 3 | ||
| L01XE23 | DABRAFENIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | DABRAFENIBUM | DIGOXINUM, TRAMETINIBUM | November 2025 | April 2026 · 2 versions | 2 | |
| L01XE23-25 | DABRAFENIBUM + DCI TRAMETINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | DABRAFENIBUM, TRAMETINIBUM | IBUPROFENUM, PARACETAMOLUM | November 2025 | April 2026 · 2 versions | 2 | |
| L01XE24 | PONATINIB | In force | L – Antineoplastic and immunomodulating agents | C2-P 3 | NO | PONATINIBUM | DASATINIBUM, IMATINIBUM, NILOTINIBUM | November 2025 | November 2025 | 1 | ||
| L01XE26 | CABOZANTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | CABOZANTINIBUM | SORAFENIBUM | November 2025 | April 2026 · 2 versions | 2 | ||
| L01XE27 | IBRUTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | IBRUTINIBUM | BENDAMUSTINUM, CISPLATINUM, DOXORUBICINUM, OBINUTUZUMABUM, OXALIPLATINUM, PREDNISOLONUM, PREDNISONUM, RITUXIMABUM, VENETOCLAX, VINCRISTINUM | November 2025 | March 2026 · 2 versions | 2 | ||
| L01XE28 | CERITINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | CERITINIBUM | CRIZOTINIBUM | November 2025 | November 2025 | 1 | ||
| L01XE31 | NINTEDANIBUM (OFEV) | In force | L – Antineoplastic and immunomodulating agents | C1-G31h | NO | NINTEDANIBUM | CARBAMAZEPINUM, CICLOSPORINUM, GELATINUM, KETOCONAZOLUM, OXIGENUM, RIFAMPICINUM | November 2025 | November 2025 | 1 | ||
| L01XE33 | PALBOCICLIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | PALBOCICLIBUM | FULVESTRANTUM, LETROZOLUM, PROGESTERONUM | November 2025 | November 2025 | 1 | |
| L01XE35 | OSIMERTINIB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | OSIMERTINIB | CARBOPLATINUM, CISPLATINUM, PEMETREXEDUM | November 2025 | November 2025 | 1 | |
| L01XE36 | ALECTINIB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | ALECTINIB | CRIZOTINIBUM | November 2025 | November 2025 | 1 | ||
| L01XE39 | MIDOSTAURINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | MIDOSTAURINUM | CARBAMAZEPINUM, DAUNORUBICINUM, ENZALUTAMIDUM, RIFAMPICINUM | November 2025 | November 2025 | 1 | ||
| L01XE42 | RIBOCICLIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | RIBOCICLIBUM | FULVESTRANTUM, GOSERELINUM, PROGESTERONUM | November 2025 | November 2025 | 1 | ||
| L01XE44 | LORLATINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | LORLATINIBUM | ALECTINIB, CARBAMAZEPINUM, CERITINIBUM, CRIZOTINIBUM, ENZALUTAMIDUM, MITOTANUM, RIFAMPICINUM | November 2025 | November 2025 | 1 | ||
| L01XE50 | ABEMACICLIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | ABEMACICLIBUM | FULVESTRANTUM, LOPERAMIDUM, PROGESTERONUM, RALOXIFENUM, TAMOXIFENUM | November 2025 | July 2026 · 2 versions | 2 | |
| L01XE54 | GILTERITINIB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | GILTERITINIB | ITRACONAZOLUM, POSACONAZOLUM, VORICONAZOLUM | November 2025 | July 2026 · 2 versions | 2 | ||
| L01XK52 | COMBINAŢII (NIRAPARIBUM + ABIRATERONUM) | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI | ABIRATERONUM, NIRAPARIBUM | PREDNISOLONUM, PREDNISONUM, TESTOSTERONUM | April 2026 | April 2026 | 1 | |
| L01XM02 | IVOSIDENIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, MEDICII DE FAMILIE DESEMNATI PENTRU COLANGIOCARCINOM | IVOSIDENIBUM | AZACITIDINUM | April 2026 | April 2026 | 1 | |
| L01XX19 | IRINOTECANUM (ONIVYDE PEGYLATED LIPOSOMAL) | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | IRINOTECANUM | ERLOTINIBUM, FLUOROURACILUM, GEMCITABINUM, OXALIPLATINUM | November 2025 | November 2025 | 1 | ||
| L01XX24 | PEGASPARGASUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | PEGASPARGASUM | ASPARAGINAZUM, DAUNORUBICINUM, FIBRINOGEN, IMATINIBUM, MERCAPTOPURINUM, OXIGENUM, PREDNISONUM, VINCRISTINUM | November 2025 | November 2025 | 1 | ||
| L01XX27 | ARSENICUM TRIOXIDUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | ARSENICUM TRIOXIDUM | PREDNISONUM | November 2025 | November 2025 | 1 | ||
| L01XX41 | ERIBULINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | ERIBULINUM | November 2025 | November 2025 | 1 | |||
| L01XX42 | PANOBINOSTATUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | PANOBINOSTATUM | BORTEZOMIBUM, ITRACONAZOLUM, KETOCONAZOLUM, LOPERAMIDUM, POSACONAZOLUM, RITONAVIRUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | ||
| L01XX44 | AFLIBERCEPTUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | AFLIBERCEPTUM | FLUOROURACILUM, IRINOTECANUM, OXALIPLATINUM | November 2025 | November 2025 | 1 | ||
| L01XX45 | CARFILZOMIBUM | In force | L – Antineoplastic and immunomodulating agents | C3- P3 | NO | CARFILZOMIBUM | DARATUMUMABUM, LENALIDOMIDUM | November 2025 | November 2025 | 1 | ||
| L01XX46 | OLAPARIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | OLAPARIBUM | ABIRATERONUM, BEVACIZUMABUM, PREDNISOLONUM, PREDNISONUM | November 2025 | November 2025 | 1 | |
| L01XX50 | IXAZOMIB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | IXAZOMIB | CARBAMAZEPINUM, LENALIDOMIDUM, RIFAMPICINUM | November 2025 | November 2025 | 1 | ||
| L01XX52 | VENETOCLAX | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | VENETOCLAX | AZACITIDINUM, BOSENTANUM, CARBAMAZEPINUM, CIPROFLOXACINUM, DECITABINUM, DIGOXINUM, DILTIAZEMUM, EFAVIRENZUM, ETRAVIRINUM, EVEROLIMUS, FLUCONAZOLUM, ITRACONAZOLUM, KETOCONAZOLUM, MODAFINILUM, OBINUTUZUMABUM, POSACONAZOLUM, RIFAMPICINUM, RITONAVIRUM, RITUXIMABUM, SIROLIMUS, VERAPAMILUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | ||
| L01XX60 | TALAZOPARIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | TALAZOPARIBUM | January 2026 | January 2026 | 1 | ||
| L01XX63 | GLASDEGIB | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | GLASDEGIB | November 2025 | November 2025 | 1 | |||
| L01XX71 | TISAGENLECLEUCEL | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TISAGENLECLEUCEL | BENDAMUSTINUM, DEXTRANUM, ETOPOSIDUM, FIBRINOGEN, FLUDARABINUM, OXIGENUM, PARACETAMOLUM, TOCILIZUMABUM | November 2025 | April 2026 · 2 versions | 2 | ||
| L01XX75 | TEBENTAFUSPUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TEBENTAFUSPUM | TOCILIZUMABUM | January 2026 | January 2026 | 1 | ||
| L01XY02 | PERTUZUMABUM + TRASTUZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | PERTUZUMABUM, TRASTUZUMABUM | DOCETAXELUM | November 2025 | November 2025 | 1 | ||
| L020F | BUPROPIONUM | In force | L – Antineoplastic and immunomodulating agents | B | YES | BUPROPIONUM | NICOTINUM | November 2025 | November 2025 | 1 | ||
| L022B | EPOETINUM ÎN ANEMIA ONCOLOGICĂ | In force | L – Antineoplastic and immunomodulating agents | C1-G10 | NO | EPOETINUM | EPOETINUM BETA, EPOETINUM ZETA | November 2025 | November 2025 | 1 | ||
| L025C | CYPROTERONUM | In force | L – Antineoplastic and immunomodulating agents | C1-G10 | NO | CYPROTERONUM | November 2025 | November 2025 | 1 | |||
| L026C | TRASTUZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TRASTUZUMABUM | CAPECITABINUM, CARBOPLATINUM, DOCETAXELUM, DOXORUBICINUM, FLUOROURACILUM, PACLITAXELUM | November 2025 | November 2025 | 1 | ||
| L02BB04 | ENZALUTAMIDUM | In force | L – Antineoplastic and immunomodulating agents | C2-P 3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | ENZALUTAMIDUM | ABIRATERONUM, AMIODARONUM, DOCETAXELUM, KETOCONAZOLUM, MOXIFLOXACINUM, SOTALOLUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | |
| L02BB05 | APALUTAMIDUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | APALUTAMIDUM | ABIRATERONUM, ENZALUTAMIDUM, KETOCONAZOLUM, TESTOSTERONUM | November 2025 | July 2026 · 2 versions | 2 | |
| L02BB06 | DAROLUTAMIDUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | DAROLUTAMIDUM | ABIRATERONUM, APALUTAMIDUM, DOCETAXELUM, ENZALUTAMIDUM, KETOCONAZOLUM, TESTOSTERONUM | January 2026 | January 2026 | 1 | |
| L02BX03 | ABIRATERONUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | ABIRATERONUM | CLOMIFENUM, DOCETAXELUM, ESTRADIOLUM, FOLLITROPINUM ALFA, HEPARINUM, LETROZOLUM, LUTROPINA, LUTROPINUM ALFA, NICOTINUM, PREDNISOLONUM, PREDNISONUM, PROGESTERONUM, SULFASALAZINUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | |
| L02BX04 | RELUGOLIXUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | RELUGOLIXUM | TESTOSTERONUM | January 2026 | April 2026 · 2 versions | 2 | ||
| L031C | ERLOTINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | ERLOTINIBUM | GEMCITABINUM | November 2025 | November 2025 | 1 | |
| L033C | TRASTUZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | TRASTUZUMABUM | November 2025 | November 2025 | 1 | |||
| L034K | BOALĂ CRONICĂ INFLAMATORIE INTESTINALĂ | In force | L – Antineoplastic and immunomodulating agents | C1-G31.A | NO* | NU pentru medicatia biologica. DA (DOAR TERAPIA STANDARD LA INDICATIA MEDICULUI SPECIALIST) | ADALIMUMABUM, AZATHIOPRINUM, BUDESONIDUM, CICLOSPORINUM, CIPROFLOXACINUM … | ADALIMUMABUM, AZATHIOPRINUM, BUDESONIDUM, CICLOSPORINUM, CIPROFLOXACINUM, FILGOTINIBUM, INFLIXIMABUM, MERCAPTOPURINUM, MESALAZINUM, METRONIDAZOLUM, OZANIMODUM, PREDNISONUM, RIFAXIMINUM, RISANKIZUMABUM, SULFASALAZINUM, TACROLIMUSUM, TOFACITINIBUM, UPADACITINIBUM, USTEKINUMABUM, VEDOLIZUMABUM | November 2025 | July 2026 · 4 versions | 4 | |
| L037C | CETUXIMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | CETUXIMABUM | CAPECITABINUM, CARBOPLATINUM, CISPLATINUM, DOCETAXELUM, FLUOROURACILUM, IRINOTECANUM, OXALIPLATINUM, PACLITAXELUM | November 2025 | November 2025 | 1 | ||
| L038C | SORAFENIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | SORAFENIBUM | INTERFERONUM | November 2025 | November 2025 | 1 | |
| L039C | LEUPRORELINUM | In force | L – Antineoplastic and immunomodulating agents | B si C2-P3 | NO* | NU pentru sublista B; DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative, pentru C2-P3 | LEUPRORELINUM | BICALUTAMIDUM, ESTRADIOLUM, FLUTAMIDUM, PROGESTERONUM, TAMOXIFENUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | |
| L039M | ARTRITA IDIOPATICĂ JUVENILĂ - AGENŢI BIOLOGICI: ADALIMUMABUM**1 (original și biosimilar), ETANERCEPTUM**1 (original și biosimilar), ABATACEPTUM**1, TOCILIZUMABUM**1(original și bio… | In force | L – Antineoplastic and immunomodulating agents | C1-G31E | NO | ABATACEPTUM, ADALIMUMABUM, ANAKINRA, CANAKINUMABUM, ETANERCEPTUM, GOLIMUMABUM +2 | AZATHIOPRINUM, CICLOSPORINUM, INTERFERONUM, PREDNISOLONUM, PREDNISONUM, SULFASALAZINUM, TRIAMCINOLONUM | November 2025 | April 2026 · 2 versions | 2 | ||
| L03AA14 | LIPEGFILGRASTIMUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | LIPEGFILGRASTIMUM | November 2025 | November 2025 | 1 | |||
| L03AB15 | ROPEGINTERFERON ALFA-2B | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | ROPEGINTERFERON ALFA-2B | November 2025 | November 2025 | 1 | ||
| L03AX03 | VACCIN BCG | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | VACCIN BCG | TUBERCULINUM | November 2025 | November 2025 | 1 | ||
| L040C | GOSERELINUM | In force | L – Antineoplastic and immunomodulating agents | B si C2-P3 | NO* | NU pentru sublista B; DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative, pentru C2-P3 | GOSERELINUM | LEUPRORELINUM, TRIPTORELINUM | November 2025 | November 2025 | 1 | |
| L040M | ARTRITA PSORIAZICĂ – AGENŢI BIOLOGICI: ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZUMABUM**1, ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR), GOLIMUMABUM**1, INFLIXIMABUM**1 (ORIGI… | In force | L – Antineoplastic and immunomodulating agents | C1-G31C | NO | ADALIMUMABUM, APREMILASTUM, BIMEKIZUMABUM, CERTOLIZUMABUM, ETANERCEPTUM, GOLIMUMABUM +7 | CARBAMAZEPINUM, CERTOLIZUMAB PEGOL, CICLOSPORINUM, DOMPERIDONUM, GRANISETRONUM, INTERFERONUM, ITRACONAZOLUM, KETOCONAZOLUM, LEFLUNOMIDUM, ONDASETRONUM, POSACONAZOLUM, RIFAMPICINUM, SULFASALAZINUM, TACROLIMUSUM, VORICONAZOLUM | November 2025 | July 2026 · 4 versions | 4 | ||
| L041M | SPONDILOARTRITA AXIALĂ, INCLUZÂND SPONDILITA ANCHILOZANTĂ ȘI SPONDILOARTRITA AXIALĂ NONRADIOGRAFICĂ - AGENŢI BIOLOGICI: ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZUMABUM**1,… | In force | L – Antineoplastic and immunomodulating agents | C1-G31D | NO | ADALIMUMABUM, CERTOLIZUMABUM, ETANERCEPTUM, GOLIMUMABUM, INFLIXIMABUM, IXEKIZUMABUM +3 | CERTOLIZUMAB PEGOL, CICLOSPORINUM, INTERFERONUM, ITRACONAZOLUM, KETOCONAZOLUM, POSACONAZOLUM, SULFASALAZINUM, TACROLIMUSUM, VORICONAZOLUM | November 2025 | January 2026 · 2 versions | 2 | ||
| L042C | SUNITINIBUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | SUNITINIBUM | BEVACIZUMABUM, IMATINIBUM, INTERFERONUM, KETOCONAZOLUM, RIFAMPICINUM, SORAFENIBUM | November 2025 | November 2025 | 1 | |
| L043M | POLIARTRITA REUMATOIDĂ - AGENŢI BIOLOGICI: INFLIXIMABUM**1 (ORIGINAL ŞI BIOSIMILAR), ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR), ADALIMUMABUM**1 (ORIGINAL ŞI BIOSIMILAR), GOLIMUMABUM… | In force | L – Antineoplastic and immunomodulating agents | C1-G31B | NO | ABATACEPTUM, ADALIMUMABUM, BARICITINIBUM, CERTOLIZUMABUM, ETANERCEPTUM, FILGOTINIBUM +6 | CARVEDILOLUM, CERTOLIZUMAB PEGOL, CICLOSPORINUM, DILTIAZEMUM, DOMPERIDONUM, FENOFIBRATUM, FLUCONAZOLUM, GRANISETRONUM, INTERFERONUM, ITRACONAZOLUM, KETOCONAZOLUM, LEFLUNOMIDUM, ONDANSETRONUM, PARACETAMOLUM, POSACONAZOLUM, SIMVASTATINUM, SULFASALAZINUM, TACROLIMUSUM, TUBERCULINUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | ||
| L044L | PSORIAZIS CRONIC SEVER (ÎN PLĂCI) - AGENŢI BIOLOGICI ŞI TERAPII CU MOLECULE MICI CU ACŢIUNE INTRACELULARĂ | In force | L – Antineoplastic and immunomodulating agents | C1-G31F | YES | DA,pe baza scrisorii medicale | ACITRETINUM, ADALIMUMABUM, APREMILASTUM, BIMEKIZUMABUM, CALCIPOTRIOLUM … | ACITRETINUM, ADALIMUMABUM, APREMILASTUM, BIMEKIZUMABUM, CALCIPOTRIOLUM, CERTOLIZUMAB PEGOL, CERTOLIZUMABUM, CICLOSPORINUM, DEUCRAVACITINIBUM, ETANERCEPTUM, GUSELKUMABUM, INFLIXIMABUM, INTERFERONUM, IXEKIZUMABUM, RISANKIZUMABUM, SECUKINUMABUM, TILDRAKIZUMABUM, TUBERCULINUM, USTEKINUMABUM | November 2025 | July 2026 · 4 versions | 4 | |
| L047E | TRIPTORELINUM | In force | L – Antineoplastic and immunomodulating agents | B | NO* | NU endiometrioza; DA, pentru pubertatea precoce | TRIPTORELINUM | ESTRADIOLUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | |
| L048C | FLUDARABINUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative, pentru formele cu administrare orala | FLUDARABINUM | ALEMTUZUMABUM, IDARUBICINUM, PREDNISOLONUM, RITUXIMABUM | November 2025 | November 2025 | 1 | |
| L04AA03 | IMUNOGLOBULINA ANTI-LIMFOCITE | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | IMUNOGLOBULINA ANTI-LIMFOCITE | CICLOSPORINUM | November 2025 | November 2025 | 1 | ||
| L04AA10 | SIROLIMUS | In force | L – Antineoplastic and immunomodulating agents | C2-P6.28 | YES | SIROLIMUS | CARBAMAZEPINUM, CIMETIDINUM, CLOTRIMAZOLUM, DILTIAZEMUM, DOPAMINUM, FLUCONAZOLUM, ITRACONAZOLUM, KETOCONAZOLUM, METOCLOPRAMIDUM, NICARDIPINUM, RIFAMPICINUM, RITONAVIRUM, VERAPAMILUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | ||
| L04AA25-HPN | ECULIZUMABUM-HEMOGLOBINURIE PAROXISTICA NOCTURNA(HPN) | In force | L – Antineoplastic and immunomodulating agents | C2-P6.30 | NO | ECULIZUMABUM | November 2025 | November 2025 | 1 | |||
| L04AA25-SHUA | ECULIZUMABUM-SINDROM HEMOLITIC UREMIC ATIPIC(SHUa) | In force | L – Antineoplastic and immunomodulating agents | C2-P6.30 | NO | November 2025 | November 2025 | 1 | ||||
| L04AA26-51 | LUPUS ERITEMATOS SISTEMIC - AGENŢI BIOLOGICI: BELIMUMABUM**1, ANIFROLUMABUM**1 | In force | L – Antineoplastic and immunomodulating agents | C1-G17 | NO | ANIFROLUMABUM, BELIMUMABUM | CICLOSPORINUM, DAPSONUM, IBUPROFENUM, INTERFERONUM, LEFLUNOMIDUM, NAPROXENUM, PIROXICAMUM, PREDNISONUM, RITUXIMABUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | ||
| L04AA43-HPN | RAVULIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P6.30 | NO | RAVULIZUMABUM | ECULIZUMABUM | November 2025 | November 2025 | 1 | ||
| L04AA43-SHUA | RAVULIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P6.30 | NO | RAVULIZUMABUM | AMINOACIZI, ECULIZUMABUM | November 2025 | November 2025 | 1 | ||
| L04AA58 | EFGARTIGIMODUM ALFA | In force | L – Antineoplastic and immunomodulating agents | C1-G13 | NO | EFGARTIGIMODUM ALFA | January 2026 | March 2026 · 2 versions | 2 | |||
| L04AB04-HS | ADALIMUMABUM | In force | L – Antineoplastic and immunomodulating agents | C1-G18 | NO | ADALIMUMABUM | TUBERCULINUM | November 2025 | November 2025 | 1 | ||
| L04AB04-UV | ADALIMUMABUM | In force | L – Antineoplastic and immunomodulating agents | C1-G18 | NO | ADALIMUMABUM | CICLOSPORINUM, INTERFERONUM, TUBERCULINUM | November 2025 | November 2025 | 1 | ||
| L04AC03 | ANAKINRA | In force | L – Antineoplastic and immunomodulating agents | C1-G31i | NO | ANAKINRA | COLCHICINUM, INTERFERONUM | April 2026 | April 2026 | 1 | ||
| L04AC07 | TOCILIZUMABUM (concentrația 162 mg) | In force | L – Antineoplastic and immunomodulating agents | C1-G31B | NO | TOCILIZUMABUM | November 2025 | November 2025 | 1 | |||
| L04AC08 | CANAKINUMABUM | In force | L – Antineoplastic and immunomodulating agents | C1-G31I | NO | CANAKINUMABUM | COLCHICINUM, INTERFERONUM, TUBERCULINUM | November 2025 | November 2025 | 1 | ||
| L04AC11 | SILTUXIMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-PNS 6.25 | NO | SILTUXIMABUM | November 2025 | November 2025 | 1 | |||
| L04AC19 | SATRALIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C1-G12 | NO | SATRALIZUMABUM | ARGININUM | November 2025 | November 2025 | 1 | ||
| L04AF-AC | ARTERITA CU CELULE GIGANTE - AGENȚI BIOLOGICI: DCI TOCILIZUMABUM**1 (concentrația 162 mg - original și biosimilar) ȘI REMISIVE SINTETICE ȚINTITE: DCI UPADACITINIBUM**1 | In force | L – Antineoplastic and immunomodulating agents | C1-G17 | NO | TOCILIZUMABUM, UPADACITINIBUM | CICLOSPORINUM, MERCAPTOPURINUM, TACROLIMUSUM | April 2026 | April 2026 | 1 | ||
| L04AJ01-MGG | ECULIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P 6.27 | NO | ECULIZUMABUM | April 2026 | April 2026 | 1 | |||
| L04AJ01-TSNMO | ECULIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P 6.27 | NO | ECULIZUMABUM | April 2026 | April 2026 | 1 | |||
| L04AJ03 | PEGCETACOPLANUM | In force | L – Antineoplastic and immunomodulating agents | C2-P 6.27 | NO | PEGCETACOPLANUM | April 2026 | April 2026 | 1 | |||
| L04AJ07 | CROVALIMABUM | In force | L – Antineoplastic and immunomodulating agents | C2-P 6.30 | NO | CROVALIMABUM | April 2026 | April 2026 | 1 | |||
| L04AL02 | ROZANOLIXIZUMABUM | In force | L – Antineoplastic and immunomodulating agents | C1-G13 | NO | ROZANOLIXIZUMABUM | April 2026 | April 2026 | 1 | |||
| L04AX02 | TALIDOMIDUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | YES | DA, doar medicii desemnati,conform Normelor tehnice de realizare a programelor nationale de sanatate curative | TALIDOMIDUM | PREDNISONUM | November 2025 | November 2025 | 1 | |
| L04AX04 | LENALIDOMIDUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | LENALIDOMIDUM | BORTEZOMIBUM, DESOGESTRELUM, LEVONORGESTRELUM, PREDNISONUM, PROGESTERONUM, TALIDOMIDUM | November 2025 | November 2025 | 1 | ||
| L04AX06 | POMALIDOMIDUM | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | POMALIDOMIDUM | BORTEZOMIBUM, CLOPIDOGRELUM, DESOGESTRELUM, HEPARINUM, LENALIDOMIDUM, LEVONORGESTRELUM, PROGESTERONUM, TALIDOMIDUM | November 2025 | November 2025 | 1 | ||
| L04AX08 | DARVADSTROCEL | Repealed · January 2026 | January 2026 | L – Antineoplastic and immunomodulating agents | C2-P6.27 | NO | DARVADSTROCEL | CIPROFLOXACINUM, MERCAPTOPURINUM, METRONIDAZOLUM | November 2025 | November 2025 | 1 | |
| L050C | INTERFERONUM ALFA 2A | In force | L – Antineoplastic and immunomodulating agents | C2-P3 | NO | INTERFERONUM | DOXORUBICINUM, PARACETAMOLUM, PREDNISONUM, VINBLASTINUM, VINCRISTINUM, ZIDOVUDINUM | November 2025 | November 2025 | 1 | ||
| LB01B | HEPATITĂ CRONICĂ ŞI CIROZĂ HEPATICĂ CU VIRUS VHB | In force | L – Antineoplastic and immunomodulating agents | C1-G4,G7 | YES | DA, pentru analogi nucleotidici/nucleozidici | ADEFOVIRUM, ALEMTUZUMABUM, CICLOSPORINUM, DIPIVOXILUM, EMTRICITABINUM … | ADEFOVIRUM, ALEMTUZUMABUM, CICLOSPORINUM, DIPIVOXILUM, EMTRICITABINUM, ENTECAVIRUM, ETRAVIRINUM, INTERFERONUM, LAMIVUDINUM, NATALIZUMABUM, OFATUMUMABUM, PEGINTERFERONUM, RITUXIMABUM, TACROLIMUSUM, TENOFOVIR, TENOFOVIRUM ALAFENAMIDA, TENOFOVIRUM DISOPROXIL | November 2025 | July 2026 · 3 versions | 3 | |
| M003M | OSTEOPOROZA - ACIDUM ALENDRONICUM**; ACIDUM RISEDRONICUM**; ACIDUM ZOLENDRONICUM**; COMBINAŢII (ACIDUM ALENDRONICUM + COLECALCIFEROLUM)**; DENOSUMABUM(Prolia)**; TERIPARATIDUM**(or… | In force | M – Musculo-skeletal system | C2-P7(eliberare prin farmaciile cu circuit inchis ale unitatilor sanitare cu paturi prin care se deruleaza programul) | NO | ACIDUM ALENDRONICUM, ACIDUM RISEDRONICUM, COLECALCIFEROLUM, DENOSUMABUM, TERIPARATIDUM, ZOLENDRONICUM | ALFACALCIDOLUM, CALCITRIOLUM, ESTRADIOLUM, PREDNISONUM, RALOXIFENUM, TESTOSTERONUM, TIBOLONUM | November 2025 | November 2025 | 1 | ||
| M01AE52 | COMBINATII(NAPROXENUM+ESOMEPRAZOLUM) | In force | M – Musculo-skeletal system | B | YES | DA (si initiere) | ESOMEPRAZOLUM, NAPROXENUM | ACIDUM ALENDRONICUM, ACIDUM RISEDRONICUM, ATAZANAVIRUM, COLECALCIFEROLUM, DENOSUMABUM, TERIPARATIDUM, ZOLENDRONICUM | November 2025 | November 2025 | 1 | |
| M03BX04 | TOLPERISONUM | In force | M – Musculo-skeletal system | D | YES | DA,in dozele si pe durata mentionate in scrisoarea medicală | TOLPERISONUM | ATOMOXETINUM, METOPROLOLUM, NEBIVOLOLUM | November 2025 | November 2025 | 1 | |
| M05BX04 | DENOSUMAB (60 mg/ml) | In force | M – Musculo-skeletal system | C1-G22 | NO | DENOSUMABUM | ALFACALCIDOLUM, PREDNISONUM | November 2025 | January 2026 · 2 versions | 2 | ||
| M05BX04-ONCO | DENOSUMAB | In force | M – Musculo-skeletal system | C2-P3 | NO | DENOSUMABUM | January 2026 | January 2026 | 1 | |||
| M05BX05 | BUROSUMABUM | In force | M – Musculo-skeletal system | C1-G22 | NO | BUROSUMABUM | AMINOACIZI, SOMATOSTATINUM | November 2025 | November 2025 | 1 | ||
| M05BX07 | VOSORITIDUM | In force | M – Musculo-skeletal system | C3 | NO | VOSORITIDUM | OXIGENUM | January 2026 | July 2026 · 3 versions | 3 | ||
| M09AX01 | ACIDUM HIALURONICUM | In force | M – Musculo-skeletal system | D | NO | ACIDUM HIALURONICUM | November 2025 | November 2025 | 1 | |||
| M09AX03 | ATALUREN | In force | M – Musculo-skeletal system | C2- P6.21 | NO | ATALUREN | ACICLOVIRUM, ADEFOVIRUM, ATORVASTATINUM, CAPTOPRILUM, CICLOSPORINUM, FAMOTIDINUM, FUROSEMIDUM, GENTAMICINUM, MACROGOLUM, OSELTAMIVIRUM, PITAVASTATINUM, RIFAMPICINUM, ROSUVASTATINUM, SITAGLIPTINUM, TELMISARTANUM, VALSARTANUM | November 2025 | November 2025 | 1 | ||
| M09AX07 | NUSINERSENUM | In force | M – Musculo-skeletal system | C2-P 6.24 | NO | NUSINERSENUM | SALBUTAMOLUM | November 2025 | November 2025 | 1 | ||
| M09AX09 | ONASEMNOGEN ABEPARVOVEC | In force | M – Musculo-skeletal system | C2-P6.24 | NO | ONASEMNOGEN ABEPARVOVEC | FIBRINOGEN, NUSINERSENUM, PREDNISONUM, RISDIPLAMUM | November 2025 | November 2025 | 1 | ||
| M09AX10 | RISDIPLAMUM | In force | M – Musculo-skeletal system | C2-P6.24 | NO | RISDIPLAMUM | FIBRINOGEN, NUSINERSENUM, ONASEMNOGEN ABEPARVOVEC | November 2025 | January 2026 · 2 versions | 2 | ||
| N001F | MEMANTINUM | In force | N – Nervous system | C1-G16 | YES | MEMANTINUM | DONEPEZILUM, GALANTAMINUM, RIVASTIGMINUM | November 2025 | November 2025 | 1 | ||
| N0020F | ATOMOXETINUM | In force | N – Nervous system | C1-G15 | YES | ATOMOXETINUM | November 2025 | November 2025 | 1 | |||
| N0021F | METHYLFENIDATUM | In force | N – Nervous system | C3 | YES | METHYLFENIDATUM | ATOMOXETINUM | November 2025 | November 2025 | 1 | ||
| N0026G | ROTIGOTINUM | In force | N – Nervous system | C1-G12 | YES | ROTIGOTINUM | LEVODOPUM | November 2025 | November 2025 | 1 | ||
| N002F | MILNACIPRANUM | In force | N – Nervous system | B si C1-G15 | NO | MILNACIPRANUM | ACIDUM VALPROICUM, CITALOPRAMUM, DULOXETINUM, ESCITALOPRAMUM, LAMOTRIGINUM, TIANEPTINUM, TRAZODONUM, VENLAFAXINUM | November 2025 | November 2025 | 1 | ||
| N003F | OLANZAPINUM | In force | N – Nervous system | C1-G15 | YES | DA, pentru formele orale | OLANZAPINUM | November 2025 | November 2025 | 1 | ||
| N004F | RISPERIDONUM | In force | N – Nervous system | C1-G15 | YES | DA, pentru formele orale | RISPERIDONUM | November 2025 | November 2025 | 1 | ||
| N005F | QUETIAPINUM | In force | N – Nervous system | C1-G15 | YES | November 2025 | November 2025 | 1 | ||||
| N006F | AMISULPRIDUM | In force | N – Nervous system | C1-G15 | YES | AMISULPRIDUM | November 2025 | November 2025 | 1 | |||
| N007F | ARIPIPRAZOLUM | In force | N – Nervous system | C1-G15 | YES | DA, pentru formele orale | ARIPIPRAZOLUM | November 2025 | July 2026 · 2 versions | 2 | ||
| N008F | CITALOPRAMUM | In force | N – Nervous system | A si C1-G15 | YES | CITALOPRAMUM | November 2025 | November 2025 | 1 | |||
| N009F | ESCITALOPRAMUM | In force | N – Nervous system | B si C1-G15 | YES | ESCITALOPRAMUM | November 2025 | November 2025 | 1 | |||
| N010F | TRAZODONUM | In force | N – Nervous system | B si C1-G15 | YES | DA; medicul de familie poate iniţia tratamentul în cazul episodului depresiv uşor, tulburărilor de anxietate uşoare sau insomniilor non- organice, cu evaluarea raportului risc-beneficiu | TRAZODONUM | November 2025 | November 2025 | 1 | ||
| N011F | TIANEPTINUM | In force | N – Nervous system | B si C1-G15 | YES | TIANEPTINUM | November 2025 | November 2025 | 1 | |||
| N012F | LAMOTRIGINUM | In force | N – Nervous system | C1-G11, G15 | YES | LAMOTRIGINUM | November 2025 | November 2025 | 1 | |||
| N013F | VENLAFAXINUM | In force | N – Nervous system | C1-G15 | YES | VENLAFAXINUM | November 2025 | November 2025 | 1 | |||
| N014F | DULOXETINUM | In force | N – Nervous system | B si C1-G15 | YES | DULOXETINUM | November 2025 | November 2025 | 1 | |||
| N015F | FLUPENTIXOLUM | In force | N – Nervous system | C1-G15 | NO | FLUPENTIXOLUM | November 2025 | November 2025 | 1 | |||
| N016F | CLOZAPINUM | In force | N – Nervous system | C1-G15 | NO | CLOZAPINUM | November 2025 | November 2025 | 1 | |||
| N017F | SERTINDOL | In force | N – Nervous system | C1-G15 | NO | SERTINDOL | November 2025 | November 2025 | 1 | |||
| N018F | ZIPRASIDONUM | In force | N – Nervous system | C1-G15 | YES | ZIPRASIDONUM | November 2025 | November 2025 | 1 | |||
| N019F | ZUCLOPENTHIXOLUM | In force | N – Nervous system | C1-G15 | YES | DA, cu exceptia formelor parenterale cu eliberare prelungita | ZUCLOPENTHIXOLUM | November 2025 | November 2025 | 1 | ||
| N020G | DONEPEZILUM | In force | N – Nervous system | C1-G16 | YES | DONEPEZILUM | GALANTAMINUM, MEMANTINUM, RIVASTIGMINUM | November 2025 | November 2025 | 1 | ||
| N021G | RIVASTIGMINUM | In force | N – Nervous system | C1-G16 | YES | RIVASTIGMINUM | DONEPEZILUM, GALANTAMINUM, MEMANTINUM | November 2025 | November 2025 | 1 | ||
| N022G | GALANTAMINUM | In force | N – Nervous system | C1-G16 | YES | GALANTAMINUM | DONEPEZILUM, MEMANTINUM, RIVASTIGMINUM | November 2025 | November 2025 | 1 | ||
| N024G | RILUZOLUM | In force | N – Nervous system | C2-P6.5.2 | NO | RILUZOLUM | November 2025 | November 2025 | 1 | |||
| N025G | PROTOCOL DE TRATAMENT ÎN DUREREA NEUROPATĂ | In force | N – Nervous system | * | * | BACLOFENUM, DULOXETINUM, GABAPENTINUM, LAMOTRIGINUM, LIDOCAINUM … | BACLOFENUM, DULOXETINUM, GABAPENTINUM, LAMOTRIGINUM, LIDOCAINUM, OXCARBAZEPINUM, PREGABALINUM, TRAMADOLUM, VENLAFAXINUM | November 2025 | November 2025 | 1 | ||
| N026F | HIDROLIZAT DIN CREIER DE PORCINĂ | In force | N – Nervous system | B | YES | November 2025 | November 2025 | 1 | ||||
| N028F | PALIPERIDONUM | In force | N – Nervous system | C1-G15 | YES | DA, pentru formele orale | PALIPERIDONUM | RISPERIDONUM | November 2025 | November 2025 | 1 | |
| N02CD | MIGRENA: GALCANEZUMABUM**Ω, FREMANEZUMABUM**Ω, EPTINEZUMABUM**Ω, RIM | In force | N – Nervous system | A | NO | EPTINEZUMABUM, FREMANEZUMABUM, GALCANEZUMABUM, RIMEGEPANT | March 2026 | March 2026 | 1 | |||
| N02CD02 | GALCANEZUMABUM | In force | N – Nervous system | A | NO | GALCANEZUMABUM | November 2025 | November 2025 | 1 | |||
| N030C | DURERE CRONICĂ DIN CANCER | In force | N – Nervous system | * | * | CARBAMAZEPINUM, CODEINUM, FENTANYLUM, GABAPENTINUM, HALOPERIDOLUM … | CARBAMAZEPINUM, CODEINUM, FENTANYLUM, GABAPENTINUM, HALOPERIDOLUM, MISOPROSTOLUM, OMEPRAZOLUM, PARACETAMOLUM, TRAMADOLUM | November 2025 | November 2025 | 1 | ||
| N032G | PREGABALINUM | In force | N – Nervous system | B | * | * | PREGABALINUM | November 2025 | November 2025 | 1 | ||
| N03AX17 | STIRIPENTOLUM | In force | N – Nervous system | C1-G11 | YES | STIRIPENTOLUM | ALPRAZOLAMUM, ATORVASTATINUM, CAFEINUM, CICLOSPORINUM, CLOBAZAMUM, LEVETIRACETAMUM, MIDAZOLAMUM, SIMVASTATINUM, TOPIRAMATUM | November 2025 | November 2025 | 1 | ||
| N03AX23 | BRIVARACETAMUM | In force | N – Nervous system | C1-G11 | YES | BRIVARACETAMUM | CARBAMAZEPINUM, DIAZEPAMUM, FLUCONAZOLUM, FLUVOXAMINUM, LEVETIRACETAMUM, OMEPRAZOLUM, RIFAMPICINUM | November 2025 | November 2025 | 1 | ||
| N03AX24 | CANNABIDIOLUM | In force | N – Nervous system | C1-G11 | YES | DA, in baza scrisorii medicale | CANNABIDIOLUM | CLOBAZAMUM | January 2026 | March 2026 · 2 versions | 2 | |
| N03AX26 | FENFLURAMINUM | In force | N – Nervous system | C1-G11 | NO | FENFLURAMINUM | PAROXETINUM, RIFAMPICINUM, STIRIPENTOLUM | January 2026 | April 2026 · 2 versions | 2 | ||
| N04BC07 | APOMORFINUM | In force | N – Nervous system | C1-G12 | NO | APOMORFINUM | CLOZAPINUM, DOMPERIDONUM, DOPAMINUM, ENTACAPONUM, LEVODOPUM, QUETIAPINUM, RASAGILINUM, SELEGILINUM | November 2025 | November 2025 | 1 | ||
| N05AX15 | CARIPRAZINUM | In force | N – Nervous system | C1-G15 | YES | DA, pot continua prescrierea pe o perioadă de 3 luni conform scrisorii medicale eliberate de medicul psihiatru | CARIPRAZINUM | BOSENTANUM, CARBAMAZEPINUM, COBICISTATUM, DILTIAZEMUM, EFAVIRENZUM, ETRAVIRINUM, FLUCONAZOLUM, ITRACONAZOLUM, KETOCONAZOLUM, MODAFINILUM, POSACONAZOLUM, RIFAMPICINUM, RITONAVIRUM, VERAPAMILUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | |
| N06AX26 | VORTIOXETINUM | In force | N – Nervous system | C1-G15 | YES | DA, pot continua prescrierea pe o perioadă de 3 luni conform scrisorii medicale eliberate de medicul psihiatru | VORTIOXETINUM | November 2025 | July 2026 · 2 versions | 2 | ||
| N06AX27 | ESKETAMINUM | In force | N – Nervous system | C2-P11.2 | NO | ESKETAMINUM | DULOXETINUM, ESCITALOPRAMUM, SERTRALINUM, VENLAFAXINUM | November 2025 | November 2025 | 1 | ||
| N06BX13 | IDEBENONUM | In force | N – Nervous system | C2-P6.23 | NO | IDEBENONUM | November 2025 | November 2025 | 1 | |||
| N07XX06 | TETRABENAZINUM | In force | N – Nervous system | C1-G12 | NO | TETRABENAZINUM | FLUOXETINUM, PAROXETINUM, TERBINAFINUM | November 2025 | November 2025 | 1 | ||
| N07XX07 | FAMPRIDINE | In force | N – Nervous system | A | NO | FAMPRIDINE | CICLOSPORINUM, CIMETIDINUM, ESTRADIOLUM, FAMOTIDINUM, RABEPRAZOLUM, RITONAVIRUM, TESTOSTERONUM | November 2025 | November 2025 | 1 | ||
| N07XX11 | PITOLISANTUM | In force | N – Nervous system | C1-G12 | NO | PITOLISANTUM | BUPROPIONUM, CARBAMAZEPINUM, CICLOSPORINUM, CLOMIPRAMINUM, FLUOXETINUM, MIDAZOLAMUM, MIRTAZAPINUM, PAROXETINUM, RIFAMPICINUM | November 2025 | November 2025 | 1 | ||
| N07XX12 | PATISIRANUM | In force | N – Nervous system | C2-P6.27 | NO | PATISIRANUM | AMINOACIZI, PARACETAMOLUM, RETINOLUM, TAFAMIDIS | November 2025 | November 2025 | 1 | ||
| N07XX15 | INOTERSENUM | In force | N – Nervous system | C2-P 6.27 | NO | INOTERSENUM | APIXABANUM, CLOPIDOGRELUM, HEPARINUM, RETINOLUM, RIVAROXABANUM, TROMBINA | April 2026 | April 2026 | 1 | ||
| N07XX18 | VUTRISIRANUM | In force | N – Nervous system | C2-P6.5.3 | NO | VUTRISIRANUM | AMINOACIZI, RETINOLUM | January 2026 | July 2026 · 2 versions | 2 | ||
| NG01G | PROTOCOL PENTRU TERAPIA MEDICAMENTOASĂ CRONICĂ A EPILEPSIEI | In force | N – Nervous system | C1-G11 | * | * | CARBAMAZEPINUM, CLONAZEPAMUM, ETHOSUXIMIDUM, GABAPENTINUM, LAMOTRIGINUM … | CARBAMAZEPINUM, CLONAZEPAMUM, ETHOSUXIMIDUM, GABAPENTINUM, LAMOTRIGINUM, LEVETIRACETAMUM, OXCARBAZEPINUM, PREGABALINUM, TOPIRAMATUM | November 2025 | November 2025 | 1 | |
| R001E | ERDOSTEINUM | In force | R – Respiratory system | D | YES | DA (si initiere la copii peste 15 kg) | ERDOSTEINUM | BUDESONIDUM, CICLESONIDUM, FORMOTEROLUM, INDACATEROLUM, SALBUTAMOLUM, SALMETEROLUM, TIOTROPIUM | November 2025 | November 2025 | 1 | |
| R03AC13 | FORMOTEROLUM | In force | R – Respiratory system | B | YES | FORMOTEROLUM | FORMOTEROLUM FUMARAT, SALBUTAMOLUM | November 2025 | November 2025 | 1 | ||
| R03AC18 | INDACATEROLUM | In force | R – Respiratory system | B | YES | INDACATEROLUM | TIOTROPIUM | November 2025 | November 2025 | 1 | ||
| R03AL04 | COMBINATII(INDACATEROLUM+GLICOPIRONIUM) | In force | R – Respiratory system | B | YES | GLICOPIRONIU, GLICOPIRONIUM, INDACATEROLUM | SALBUTAMOLUM | November 2025 | November 2025 | 1 | ||
| R03AL05 | COMBINAȚII (ACLIDINIUM BROMIDUM + FORMOTEROLUM FUMARAT) | In force | R – Respiratory system | B | YES | ACLIDINIUM BROMIDUM, FORMOTEROLUM FUMARAT | SALBUTAMOLUM | November 2025 | November 2025 | 1 | ||
| R03AL06 | COMBINATII(TIOTROPIUM+OLADATEROLUM) | In force | R – Respiratory system | B | YES | OLADATEROLUM, OLODATEROLUM, TIOTROPIUM | SALBUTAMOLUM | November 2025 | November 2025 | 1 | ||
| R03AL09 | BECLOMETASONUM+FORMOTEROLUM+GLICOPIRONIU BROMIDUM | In force | R – Respiratory system | B | YES | DA,în dozele și pe durata recomandată de către medicul specialist în scrisoarea medicală | BECLOMETASONUM, FORMOTEROLUM, GLICOPIRONIU BROMIDUM, GLICOPIRONIUM BROMIDUM | BUDESONIDUM, CICLESONIDUM, SALBUTAMOLUM | November 2025 | July 2026 · 3 versions | 3 | |
| R03AL11 | FORMOTEROLUM+GLICOPIRONIUM+BUDESONIDUM | In force | R – Respiratory system | B | YES | DA,în dozele și pe durata recomandată de către medicul specialist în scrisoarea medicală | BUDESONIDUM, FORMOTEROLUM, GLICOPIRONIU, GLICOPIRONIUM | November 2025 | July 2026 · 2 versions | 2 | ||
| R03BB06 | GLICOPIRONIUM | In force | R – Respiratory system | B | YES | GLICOPIRONIU, GLICOPIRONIUM | TIOTROPIUM | November 2025 | November 2025 | 1 | ||
| R03DX05 | OMALIZUMABUM | In force | R – Respiratory system | A | NO | OMALIZUMABUM | BUDESONIDUM, CICLESONIDUM | November 2025 | November 2025 | 1 | ||
| R03DX05-UCS | URTICARIE CRONICĂ SPONTANĂ – TERAPIE BIOLOGICĂ | In force | R – Respiratory system | A | YES | DA, doar in perioadele dintre evaluari dar nu poate face evaluarea sau prescriptia din momentul evaluarii | OMALIZUMABUM | OMALIZUMABUM | November 2025 | January 2026 · 2 versions | 2 | |
| R03DX10 | BENRALIZUMABUM | In force | R – Respiratory system | A | NO | BENRALIZUMABUM | BUDESONIDUM, CICLESONIDUM, PREDNISONUM, TRIAMCINOLONUM | November 2025 | November 2025 | 1 | ||
| R03DX11 | TEZEPELUMABUM | In force | R – Respiratory system | C1-G31H | NO | TEZEPELUMABUM | BUDESONIDUM, CICLESONIDUM, SALBUTAMOLUM | January 2026 | January 2026 | 1 | ||
| R07AX02 | IVACAFTORUM | In force | R – Respiratory system | C2-P6.4 | YES | DA,în baza scrisorii medicale | IVACAFTORUM | ALPRAZOLAMUM, CARBAMAZEPINUM, CICLOSPORINUM, DIAZEPAMUM, DIGOXINUM, ELEXACAFTORUM, EVEROLIMUS, FLUCONAZOLUM, ITRACONAZOLUM, KETOCONAZOLUM, MIDAZOLAMUM, POSACONAZOLUM, RIFAMPICINUM, SIROLIMUS, TACROLIMUSUM, TEZACAFTORUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | |
| R07AX30 | LUMACAFTORUM+IVACAFTORUM | In force | R – Respiratory system | C2-P6.4 | YES | DA,în baza scrisorii medicale | IVACAFTORUM, LUMACAFTORUM | BUPROPIONUM, CARBAMAZEPINUM, CICLOSPORINUM, CITALOPRAMUM, DIGOXINUM, ESCITALOPRAMUM, ESOMEPRAZOLUM, ESTRADIOLUM, EVEROLIMUS, FLUCONAZOLUM, IBUPROFENUM, ITRACONAZOLUM, KETOCONAZOLUM, LANSOPRAZOLUM, MIDAZOLAMUM, MONTELUKASTUM, OMEPRAZOLUM, POSACONAZOLUM, PREDNISONUM, REPAGLINIDUM, RIFAMPICINUM, SERTRALINUM, SIROLIMUS, TACROLIMUSUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | |
| R07AX32 | IVACAFTORUM+TEZACAFTORUM+ELEXACAFTORUM | In force | R – Respiratory system | C2-P6.4 | YES | DA,în baza scrisorii medicale | ELEXACAFTORUM, IVACAFTORUM, TEZACAFTORUM | CARBAMAZEPINUM, CICLOSPORINUM, DIGOXINUM, EVEROLIMUS, FLUCONAZOLUM, ITRACONAZOLUM, KETOCONAZOLUM, POSACONAZOLUM, RIFAMPICINUM, SIROLIMUS, TACROLIMUSUM, VERAPAMILUM, VORICONAZOLUM | November 2025 | November 2025 | 1 | |
| S01EE05 | TAFLUPROSTUM | Repealed · January 2026 | January 2026 | S – Sensory organs | C1-G26 | YES | TAFLUPROSTUM | November 2025 | November 2025 | 1 | ||
| S01LA04 | RANIBIZUMABUM | In force | S – Sensory organs | C1-G26 | NO | RANIBIZUMABUM | November 2025 | November 2025 | 1 | |||
| S01LA05 | AFLIBERCEPTUM | In force | S – Sensory organs | C1-G26 | NO | AFLIBERCEPTUM | November 2025 | July 2026 · 3 versions | 3 | |||
| S01LA06 | BROLUCIZUMABUM | In force | S – Sensory organs | C1-G26 | NO | BROLUCIZUMABUM | November 2025 | November 2025 | 1 | |||
| S01LA09 | FARICIMABUM | In force | S – Sensory organs | C1-G26 | NO | FARICIMABUM | January 2026 | March 2026 · 2 versions | 2 | |||
| S01XA18 | CICLOSPORINUM | In force | S – Sensory organs | C1-G26 | YES | CICLOSPORINUM | November 2025 | November 2025 | 1 | |||
| V001D | DEFEROXAMINUM | In force | V – Various | C1-G10 si C2-P6.1 | NO | DEFEROXAMINUM | November 2025 | November 2025 | 1 | |||
| V002D | DEFERASIROXUM | In force | V – Various | C1-G10 si C2-P6.1 | NO | DEFERASIROXUM | DEFEROXAMINUM | November 2025 | November 2025 | 1 | ||
| V003D | SEVELAMER | In force | V – Various | C2-P10 | NO | SEVELAMER | November 2025 | November 2025 | 1 | |||
| V004N | AMINOACIZI, INCLUSIV COMBINAŢII CU POLIPEPTIDE | In force | V – Various | C1-G25 | NO | AMINOACIZI | November 2025 | November 2025 | 1 | |||
| V03AE05 | OXIHIDROXID SUCROFERIC | In force | V – Various | C2-P10 | NO | OXIHIDROXID SUCROFERIC | SEVELAMER | November 2025 | November 2025 | 1 | ||
| V03AE10 | NATRII ZYIRCONII CYCLOSILICAS | In force | V – Various | C1-G1, G25, C2- P10 | YES | DA,cu excepția bolnavilor cu insuficiență renală cronică incluși în programul național de supleere a funcției renale (hemodializă cronică) pentru care prescrierea va fi realizată în circuit închis, prin centrele de dializă | AMLODIPINUM, ATAZANAVIRUM, ATORVASTATINUM, CLOPIDOGRELUM, DASATINIBUM … | AMLODIPINUM, ATAZANAVIRUM, ATORVASTATINUM, CLOPIDOGRELUM, DASATINIBUM, ERLOTINIBUM, FUROSEMIDUM, GLIPIZIDUM, ITRACONAZOLUM, KETOCONAZOLUM, LOSARTANUM, NILOTINIBUM, POSACONAZOLUM, RALTEGRAVIRUM, RILPIVIRINUM, RITONAVIRUM, SACUBITRILUM, TACROLIMUSUM, VALSARTANUM | April 2026 | April 2026 | 1 | |
| V10XX05 | LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN | In force | V – Various | C2-P3 | NO | LUTETIUM, VIPIVOTIDE TETRAXETAN | TESTOSTERONUM | April 2026 | April 2026 | 1 |